U N Mehta Institute Of Cardiology & Research Center - Gujarat

41256576 e tender for rate contract for medical laboratory blood testing outsource service (part 2) for u n mehta institute of cardiology and research centre (affiliated to b. j. medical college & nabh accredited) ahmedabad, gujarat, india. jacobsen syndrome (jbs),jak2 panel,jak2 v617f mutation by pcr,jak2 v617f mutation by sanger,jak2 v617f with reflex to exon 12,jc virus qualitative,jo 1 antibody,joubert and meckel gruber syndromes panel 18 genes,joubert syndrome (jbts) panel,juvenile polyposis syndrome bmpr1a, smad4,juvenile polyposis syndrome (jps),kabuki syndrome (kabuk) panel,kabuki syndrome panel kdm6a, kmt2d,kallmann syndrome 1 (kal1),kappa light chain,karyotype amniotic fluid,karyotype bone marrow,karyotype peripheral blood (couple),karyotype peripheral blood (husband),karyotype peripheral blood (single),karyotype products of conception,karyotype chorionic villus sampling,karyotype peripheral blood for hematological malignancy,ki 67 (ihc marker),kit and pdgfra mutation panel,kit mutations,kleefstra syndrome,klinefelter syndrome,koh examination for csf,koh preparation for fungus,koolen de vries syndrome (kdvs),krabbe disease test galc,l1 syndrome,lacosamide level,lactate level,lactate level (csf),lambda light chain,lamotrigine level,lap score,lbc pap + pcr hpv dna,lbc pap smear,ldh fluid,ldh isoenzymes,ldh serum,ldl cholesterol (direct),lead urine spot,lead level,lead level in liver biopsy,left ventricular noncompaction panel (lvnc): actc1, dsp, hcn4, lamp2, lm na, mybpc3, myh7pln, ryr2, scn5a, taz, tnni3, tnnt2, tp m1, vcl, dtna, ldb3, prdm16,lft liver function test (sgpt, sgot, billirubin total and direct, alkaline phosphatase, total protein, albumin, globulin, ag ratio),legionella igm,legionella pneumophila ag urine,legionella urinary antigen,leigh syndrome ndufs8,leigh syndrome (ls),leigh syndrome, x linked,leismania igg (ho),leismania igm (ho),leptin serum,leptospira by pcr,leptospira detection by smear examination,leptospira igg,leptospira igm,leri weill dyschondrosteosis (lwd),lesch nyhan syndrome (lns),leucocyte adhesion defect (lad),leukodystrophy, demyelinating, adult onset, autosomal dominant (adld),levetiracetam,lh,li fraumeni syndrome tp53,ligase iv syndrome test lig4,limb girdle muscular dystrophy panel 31 genes,lipase,lipase fluid,lipid profile,lipoprotein (a),liquid biopsy somatic cancer panel,liquid egfr,lissencephaly (lis) panel,lissencephaly, x linked (lisx) panel,lithium,liver profile by immunoblot,lkm 1 antibody by if,lkm antibodies elisa,loeys dietz syndrome panel smad3, tgfb2, tgfbr1, tgfbr 2, fbn1, tgfb3,long qt syndrome panel akap9, ank2, cacna1c, cav3, kcne1, kcne2, kcnh2, kcnj2, kcnj5, kcnq1, scn4b, scn5a, snta1,lowe oculocerebrorenal syndrome (ocrl),lp (a) (lipoprotein a),lubs x linked mental retardation syndrome (mrxsl),lujan syndrome test med12,lung adenocarcinoma braf,lung adenocarcinoma egfr by arms pcr,lung adenocarcinoma egfrby sanger,lung adenocarcinoma kras,lung cancer panel somatic mutations (egfr, kras, braf),lung cancer targeted gene panel (egfr kras braf met erbb2 alk1 ros1),lupus anticoagulant (la),lyme disease ( borrelia burgdorferi igm & igg ),lymphocyte subset analysis,lymphoproliferative syndrome, x linked, 1 (xlp1),lynch syndrome mlh1, msh2, msh6, pms2 (offered as single gene if there is a kfm or if there?s ihc negative staining),lynch syndrome panel epcam, mlh1, msh2, msh6, mutyh, pms2,macrocephaly/autism syndrome,magnesium,magnesium 24 hour urine,magnesium urine spot,malaria parasites,malarial antigen (rapid card) test,malignant hyperthermia susceptibility panel cacna1s, ryr1,mandibulofacial dysostosis, guion almeida type,manganese level,maple syrup urine disease panel bckdha, bckdhb, dbt,marfan syndrome (mfs),mcad common mutation analysis acadm,mdr and xdr,mdr and xdr tb rapid genotyping test,mdr tb rapid genotyping test 1st line (inh & rifampicin) lpa,mdr tb rapid genotyping test 1st line(inh and rifampicin),mds kt+fish panel (karyotyping fish del 5q del 7q del 20q cep 8),measels (rubeola) antibody igg,measels (rubeola) antibody igm,measles (rubeola) igg antibody,melanoma panel 11 genes,melanoma pancreatic cancer syndrome panel cdk4, cdkn2a,meningitis (viral) profile igg & igm by clia,mercury blood by icpms,metabolic disorder panel,metabolic study for stone,metachondromatosis (metcds),metachromatic leukodystrophy test arsa, aspa, galc, hexa, hexb,metachromatic leukodystrophy (mld),metagenome_db (metagenome genome database),metanephrine free plasma,metanephrine 24 hour urine,metatranscriptome sequencing & analysis,meth haemoglobin,methionine,methotrexate,methyl malonic acid qualitative,urine,methylmalonic acid quantitative serum,methylmalonic acidemia panel mmaa, mmab, mmachc, mm adhc, mut,mgmt methylation test,mic by e strip,micophthalmia, syndromic (mcops) panel,microalbumin,microalbumin/creatinine ratio urine,microarray product of conception,microarray 315k,microarray 315k prenatal with mcc,microarray 750k,microarray 750k prenatal with mcc,microbial identification contig (mid c),microbial identification report (mid r),microbial identification sequence (mid s),microfilaria antibody by card,microfilaria by ps,microfilaria by smear,microfilaria detection by card,microsatellite (per well tube/reaction) (sample 4),microsatellite instability (msi),microvascular complications of diabetes 1 (mvcd1),miller dieker lissencephaly syndrome (mdls),minimal residual disease by flow cytometry,mitochondrial disease panel (37 genes),mll (mixed lineage leukemia gene (mll),mlst 01 (multilocus sequence typing (mlst),mm fish and karyotyping panel,mm fish panel,modified acid fast stain,modified zn stain,mog panel,mog with nmo panel csf,mog with nmo panel seum,mohr tranebjaerg syndrome (mts),monomeric prolactin,monomeric prolactin (active prolactin),mowat wilson syndrome (mows),mp by card method,mpl w 515/s 505 mutation analysis,ms mlpa,mtb pcr,mtb/ntm pcr,mtb mdr (rif/inh),mtb xdr (fluoroquinolones/ injectable drugs),mthfr by pcr,mthfr by sanger,mucopolysaccharides (mps) qualitative urine,mucopolysaccharides (mps) screen,mucopolysaccharides (mps) typing,mucopolysaccharidosis type 3 (mps 3) panel,mucopolysaccharidosis type ii (mps2),mucopolysaccharidosis type ii test ids,mucor racemosus specific igg,multi cancer panel 79 genes,multiminicore disease panel ryr1, sepn1,multiple carboxylase deficiency panel btd, hlcs,multiple endocrine neoplasia, type 1 men1,multiple endocrine neoplasia, type 2 ret,multiple myeloma fish panel(del13q t(4;14) t(11;14) t(14;16) del17p),multiplex pcr (15,17) (11,17)(5,17) for aml,mumps antibody igg,mumps antibody igm,muscular dystrophy, duchennetype (dmd),mustishk stroke panel,mutyh associated polyposis (targeted),mycoplasma pneumonia igg,mycoplasma pneumonia igm,mycoxpert,myelodysplastic syndrome/leukemia panel 21 genes,myofibrillar myopathy panel bag3, cryab, des, dnajb6, fh l1, flnc, ldb3, myot,myoglobin serum,myotonia and paramyotonia congenita panel (2 genes),myotonic dystrophy type 1,myotonic dystrophy type 2,myotubular myopathy, x linked (cnmx),nablus mask like facial syndrome (nmlfs),nail patella syndrome (nps),nance horan syndrome (nhs),nemaline myopathy panel 10 genes,nephronophthisis 1 (nphp1),nephronophthisis panel 12genes,nervous system/brain cancer panel 39 genes,neugen ihc marker,neurodegenration with brain iron accumulation panel (upto 14 genes),neurofibromatosis type 1 test nf1,neurofibromatosis type 2 test nf2,neuronal ceroid lipofuscinoses panel cln3, cln5, cln6, cln8, ctsd, dnajc5, kctd,7mfsd8, ppt1, tpp1,neuropathy, hereditary, with liability to pressure palsies (hnpp),neurotropic virus panel,ngal (netrophil gelatinase associated lipocalin) urine,ngs glycogen storage disease comprehensive panel,ngs mucopolysaccharidoses (mps) comprehensive panel,ngs muscular dystrophy comprehensive panel,ngs myopathy comprehensive panel,ngs dkc1 dyskeratois congenita and shwachman diamond sdbs,ngs 161 gene ocav3 assay ( dna mutations cnvs rna fusions),ngs 409 gene mutation screening (snv indel) + tmb,ngs 546 gene oncomine comprehensive assay plus (dna mutations cnvs rna fusions msi tmb hrr),ngs achromatopsia cone and cone rod dystrophy,ngs adult refsum disease,ngs aicardi goutieres syndrome,ngs albinism,ngs alkaptonuria,ngs alport syndrome,ngs alzheimer dementia and dementia,ngs amyotrophic lateral sclerosis (als),ngs arrhythmia comprehensive panel,ngs arrhythmogenic cardiomyopathy,ngs arthrogryposis,ngs autism panel,ngs bardet biedl,ngs barter syndrome,ngs biotinidase deficiency,ngs b negative scid,ngs bone marrow failure syndrome gene panel,ngs b positive scid,ngs brain iron accumulation syndromes,ngs brain malformations comprehensive panel,ngs brca 1 & 2 with deletions/duplications (germline) (ngs + mlpa),ngs brca1 & 2 (germline)assay,ngs brca1 & 2 (somatic)assay,ngs breast cancer,ngs brugada syndrome,ngs cah deletion & duplication detection,ngs canavan disease,ngs cancer 12 gene panel,ngs cancer hot spot v2 panel (50 gene mutations),ngs cancer comprehensive panel,ngs cardiomyopathy and skeletal muscle disease,ngs cardiomyopathy comprehensive panel,ngs cardiomyopathy,ngs cerebellar ataxia,ngs ceroid lipofuscinosis,ngs charcot marie tooth disease,ngs childhood onset epilepsy,ngs ciliopathies,ngs combined hereditary dementia and amyotrophic lateral sclerosis,ngs combined mito genome plus mito nuclear gene,ngs congenital adrenal hyperplasia,ngs congenital diserythropoetic anaemia,ngs congenital disorders of glycosylation,ngs congenital muscular dystrophy,ngs congenital myasthenic syndrome,ngs congenital myopathy,ngs congenital neutropenia,ngs cornelia de lange syndrome,ngs cortical brain malformations?,ngs cystic fibrosis complete gene sequencing (cftr gene),ngs cystinosis,ngs cystinuria,ngs dba (diamond blackfan anaemia),ngs deafness non syndromic sensorineural autosomal dominant,ngs deafness non syndromic sensorineural autosomal recessive,ngs dilated cardiomyopathy,ngs dmd carrier deletion/duplication testing by mlpa,ngs dna extraction and storage for 5 years,ngs dystonia,ngs early infantile epileptic encephalopathy,ngs epilepsy comprehensive panel,ngs episodic ataxia,ngs eye disorders: comprehensive panel,ngs fabry disease,ngs familial hlh(hemophagocytic lymphohistiocytosis),ngs familial mediterranean fever,ngs fanconi anaemia,ngs fatty acid oxidation defects,ngs female infertility,ngs flecked retina disorders,ngs for hereditary hemolytic anemia (membranopathy and enzymopathy),ngs galactosemia,ngs gene panel test,ngs glucose 6 phosphate dehydrogenase deficiency,ngs glutaric acidemia type i,ngs glycine encephalopathy,ngs gm2 gangliosidosis,ngs hemochromatosis hfe full gene sequencing,ngs hemophilia a and b(factor viii and factor ix),ngs hereditary cancer panel (germline),ngs hereditary cancer panel with brca 1&2 deletions/duplications (ngs + mlpa),ngs hereditary hemochromatosis,ngs hereditary hemorrhagic telangiectasia,ngs hereditary neuropathy sequencing,ngs hereditary parkinson?s disease & parkinsonism,ngs hereditary spastic paraplegia,ngs hereditary thrombophilia,ngs high resolution hla typing,ngs high resolution hla typing (histogenetics),ngs homocystinuria,ngs hrd gene panel,ngs hrr gene panel,ngs hyper ige syndromes,ngs hyperphenylalaninemia,ngs hyperprolinemia,ngs hypertrophic cardiomyopathy,ngs infantile epilepsy,ngs joubert and meckel gruber syndromes,ngs krabbe disease,ngs limb malformation: sequencing,ngs limb girdle muscular dystrophy: sequencing,ngs lissencephaly,ngs liver glycogen storage disease,ngs long qt syndrome,ngs lung cancer 12 gene panel,ngs lysosomal storage disorders comprehensive panel,ngs macular dystrophy/degeneration/stargardt disease,ngs male ifertility,ngs maple syrup urine disease,ngs marfan syndrome,ngs maternal cell contamination,ngs metachromatic leukodystrophy,ngs microphthalmia/anophthalmia/coloboma spectrum,ngs mitochondrial encephalopathy/ leigh syndrome nuclear gene,ngs mitochondrial nuclear gene comprehensive panel,ngs mody panel,ngs mucolipidosis,ngs myoclonic dystonia,ngs nephrotic syndrome gene panel,ngs neuromuscular disorders comprehensive panel,ngs neuropathies comprehensive panel,ngs neurotransmitter disorders,ngs niemann pick disease types a and b,ngs niemann pick type c,ngs non ketotic hyperglycinemia,ngs noonan and rasopathies,ngs obesity panel,ngs omixome duos (ces+mtdna+cnv),ngs omixome solo (ces+mtdna+cnv),ngs omixome trios (ces+mtdna+cnv),ngs oncomine cftna lung assay (dna+rna),ngs oncomine cftna pan cancer assay (dna+rna),ngs oncomine focus assay (52 genes dna mutations cnvs rna fusions),ngs oncomine myeloid v2 gx dna only assay,ngs oncomine myeloid v2 gx rna only assay,ngs oncomine myeloid v2gx assay,ngs oncomine precison gx assay (dna mutations cnvs rna fusions)(liquid biopsy),ngs oncomine precison gx assay (dna mutations cnvs rna fusions),ngs oncomine tumour mutation burden,ngs organic acidemias,ngs overgrowth and macrocephaly syndromes,ngs periodic fever syndromes,ngs polycystic kidney,ngs pompe disease,ngs pontocerebellar hypoplasia,ngs premature ovarian failure: sequencing and fmr1 cgg repeat analysis,ngs prenatal noonan spectrum disorders,ngs prenatal omixome(ces+mtdna+cnv) + mcc,ngs prenatal uniexome(whole exome +mtdna+cnv) + mcc,ngs primary hyperoxiluria,ngs primary immunodeficiency gene panel,ngs progressive external ophthalmoplegia (peo)/optic atrophy nuclear genes,ngs progressive myoclonic epilepsy,ngs propionic acidemia,ngs pulmonary disease: comprehensive panel,ngs pulmonary fibrosis and hermansky pudlak syndrome,ngs pulmonary hypertension,ngs reanalysis and reinterp (panel exome),ngs retina/photoreceptor dystrophy,ngs retinitis pigmentosa,ngs rhizomelic chondrodysplasia punctata spectrum,ngs sandhoff disease,ngs scid comprehensive panel,ngs segregation analysis for 2 mutations in one patient,ngs segregation analysis one mutation for two family members,ngs segregation analysis only per mutation per person,ngs short qt syndrome,ngs single gene (snv+cnv),ngs skeletal dysplasia with increased bone density,ngs sma by mlpa,ngs sma carrier testing by mlpa,ngs sudden cardiac arrest (sca),ngs tay sachs disease,ngs treachers collins syndrome,ngs tuberous sclerosis,ngs typical and atypical hus,ngs tyrosinemia,ngs unicad nipt 5 chromosomes,ngs uniexome duos (whole exome +mtdna+cnv),ngs uniexome solo (whole exome +mtdna+cnv),ngs uniexome trios(whole exome +mtdna+cnv),ngs unifusion seq assay,ngs unipanel(ask us for customized panel) snv+cnv,ngs urea cycle disorders,ngs usher syndrome,ngs waardenburg syndrome,ngs wilson disease,ngs x linked thrombocytopenia,ngs zellweger spectrum disorder,ngs zellweger syndrome,nicotine level / cotinine level (urine),nicotine metabolite, serum,niemann pick type c panel npc1, npc2,nijmegen breakage syndrome test,nk cell (cd16 + cd56),nk cell (cd16 + cd56),nmda antibody csf,nmda antibody serum,nmda receptor antibody (nr1),nmo with mog antibody profile for csf,nocardia culture,non invasive prenatal testing (nipt),noonan syndrome (ns) panel,noonan syndrome panel a2ml1, braf, cbl, kras, map2 k1, map2k2, nras,ptpn11, ra f1, rit1, shoc2, sos1, actb,noonan syndrome with multiple lentigines panel braf, ptpn11, raf1,nor metanephrine free plasma,nor metanephrine 24 hour urine,notch3 mutations,npm1 (nucleophosmin gene (npm1),nras (neuroblastoma ras viral oncogene homolog),ns 1 dengue antigen (rapid),nse neuron specific enolase,nse serum,nt probnp,nystagmus, infantile periodic alternating, x linked (nys1),obesity, severe,occipital horn syndrome (ohs),occult blood stool,oculacutaneous albinism, type ii (oca2),oculo facio cardio dental syndrome test bcor,oligoclonal band csf,oligodontia colorectal cancer syndrome test axin2,opa plus (ngs oncomine precision assay + sbrca),opitz gbbb syndrome, x linked,opportunistic infection panel,oral facial digital syndrome, type 1 test ofd1,organic acidemias panel 31 genes,ornithine transcarbamylase deficiency,orofaciodigital syndrome i (ofd1),osmolality serum,osmolality urine,osmotic fragility test,osteogenesis imperfecta panel col1a1, col1a2, crtap, p3h1,osteogenesis imperfecta, type ii (oi2),osteogenesis imperfecta, type iv,otofaciocervical syndrome 1 (ofc1),oxalate 24 hour urine,p1np,p1np (procollagen type 1 amino terminal propeptide) total,p24 antigen,pallister hall syndrome (phs),pallister killian syndrome (pks),p anca (mpo) by elisa,pap smear staining and reporting,pap smear staining and reporting,pap smear liquid based cytology (lbc),papp a (pregnancy associated plasma protein a),para neoplastic profile(neuronal antigens profile),paracetamol,parietal foramina 1 (pfm),parvovirus b19 igg,parvovirus b19 igm,parvovirus b19, qualitative pcr,pas (periodic acid schif) stain,patau syndrome,paternity test,pcr chlamydia trachomatis & gonorrhoeae combo panel,pcr genital ulcer disease panel,pcr viral eye infection panel,pcr abl kinase mutation for imatinib resistance (irma),pcr adeno virus qualitative,pcr adeno virus quantitative,pcr adrb2 genotyping,pcr alpha thalassemia complete work up,pcr alpha thalassemia deletions/duplication (mlpa),pcr alpha thalassemia sequencing,pcr aml1/eto t(8:21),pcr apc gene mutation family screening,pcr apc gene mutation patient,pcr aspergillus spp. detection,pcr b cell receptor gene rearrangement,pcr bacterial identification (clinical sample),pcr basic colorectal cancer panel a (kras nras brafv600e msi),pcr basic colorectal cancer panel b (kras nras brafv600e),pcr bcr abl minor quantitative (p190),pcr bcr abl(is) quantitative (p210),pcr bcr/abl qualitative major (p210),pcr bcr/abl qualitative minor (p190),pcr bcr abl1 qualitative (p190 p210 & p230),pcr beta thalassemia,pcr beta thalassemia complete work up,pcr bk virus (qualitative),pcr bk virus (quantitative),pcr braf v600e mutation,pcr c kit gene mutation (exon 9 11 13 17) (gist/melanoma),pcr cal r mutation,pcr cbfb/myh11 for inv16,pcr cebpa mutation,pcr chikungunya and dengue (qualitative),pcr chikungunya rna (qualitative),pcr chikungunya rna (quantitative),pcr chimerism follow up sample ( post transplant patient),pcr chimerism (single sample),pcr chlamydia trachomatis,pcr c kit aml (exon 8 17),pcr cmv urine,pcr cmv (qualitative),pcr cmv quantitative,pcr covid 19,pcr cxcr4 mutation testing,pcr cyp2c*19 (clopidogrel),pcr cyp3a5 genotyping,pcr cystic fibrosis,pcr delta beta thalassemia,pcr dengue (qualitative),pcr dengue (quantitative),pcr dengue typing,pcr dnmt3a mutation,pcr dpd gene mutation,pcr duchenne / becker muscular dystrophy (dmd/bmd),pcr e2/pbx1 t(1;19),pcr ebv qualitative,pcr ebv quantitative,pcr egfr (exon 18 19 20 21) mutation,pcr egfr (exon 19) mutation,pcr egfr (exon 21) mutation,pcr endometrial cancer molecular sub classification panel,pcr factor v leiden mutation,pcr fip1l1 pdgfra fusion detection,pcr flt 3 mutation,pcr flt 3 (itd & tkd) mutation,pcr flt3 and npm1 mutation,pcr flt3 itd allelic ratio,pcr freidreichs ataxia mutation analysis,pcr fungal identification (clinical sample),pcr galt mutation,pcr gist panel (kit (exon9 11 13 17)/pdgfra (exon12 18),pcr gonorrhoeae (neisseria gonorrhoeae),pcr hbv dna qualitative,pcr hbv dna quantitative (viral load),pcr hbv dna quantitative (viral load) ivd approved,pcr hbv genotyping,pcr hcv genotyping,pcr hcv quantitative with genotyping,pcr hcv rna (qualitative),pcr hcv rna (quantitative),pcr hemophilia a inversion panel (intron 22 & 1),pcr hemophilia a (intron 1),pcr hemophilia a (intron 22),pcr hepatitis a virus (hav) detection (qualitative),pcr hfe gene mutation (hereditary hemochromatosis ),pcr hhv 6 (human herpesvirus 6) detection qualitative,pcr hhv 7 (human herpesvirus 7) detection qualitative,pcr hiv i proviral dna,pcr hiv i qualitative,pcr hiv i quantitative (viral load),pcr hiv ii quantitative (viral load),pcr hiv 1 drug resistance,pcr hla b,pcr hla b*5701,pcr hla b27,pcr hla b51 (bechets disease),pcr hla celiac disease,pcr hla cw6(c*06 psoriatic arthritis),pcr hpv dna (ffpe block),pcr hpv dna (lbc),pcr hpv screening,pcr hpv typing,pcr h ras mutation,pcr hsv qualitative,pcr hsv quantitative,pcr huntington disease mutation analysis,pcr idh 1/2 mutation,pcr igvh mutation,pcr jak 2 panel [jak2v617f & jak2 exon 12 mutation],pcr jak2 (v617f) mutation,pcr jak2 exon 12 mutation,pcr jak2 reflex panel ( jak v617f negative to exon 12 mutation),pcr japanes encephalitis csf,pcr jc virus qualitative,pcr kit gene mutation (exon 9 11 13 17) (gist/melanoma),pcr k ras mutation,pcr leptospira detection,pcr lpl panel (myd88 + cxcr4),pcr malaria (plasmodium) detection,pcr mgmt methylation assay,pcr microsatelite instability in colon cancer,pcr mll/af4 t(4:11),pcr mpl mutation,pcr mpn reflex panel 1 (bcr abl1 ql jak2v617f jak2 exon 12 calr mpl),pcr mpn reflex panel 2 ( jak2v617f jak2 exon 12 calr mpl),pcr mpn reflex panel 3 ( jak2v617f calr mpl),pcr mpn sure panel(bcrabl ql jak2v617f jak2ex12 mpl calr),pcr mthfr mutation,pcr mucormycosis,pcr myd88 gene mutation,pcr myotonic dystrophy type 1 ( dmpk gene),pcr narcolepsy (hla drb1*15 dqb1*06:02 dqa1*01:02),pcr npm 1 mutation,pcr n ras mutation,pcr nudt15 genotyping,pcr pai 1 genotyping,pcr parvovirus b 19 qualitative,pcr parvovirus b 19 quantitative,pcr pdgfr mutation,pcr pdgfra (exon 12 18) mutation,pcr pik3ca mutation,pcr pml/rara t(15;17) qualitative,pcr pml/rara t(15;17) quantitative,pcr pmp 22 ( peripheral myelin protein 22) by mlpa,pcr pneumocystis pneumonia (pcp),pcr pole gene mutation analysis (sequencing),pcr primary chimerism ( pre transplant patient & donor),pcr prothrombin mutation,pcr respiratory pathogen panel: multiplex rt pcr,pcr ret gene mutation testing (exon 10 11 13 14 15 16),pcr rickettsia detection,pcr rubella detection,pcr salmonella detection,pcr sca detection single form,pcr sma (spinal muscular atrophy) by mlpa,pcr spinal cerebral ataxia ( sca panel 1 2 3 6 7 & 12),pcr std (sexually transmitted diseases) panel,pcr t cell receptor gene rearrangement,pcr t(8;21)aml eto quantitative assay,pcr tb/ntm detection,pcr tel/aml1 t(12:21),pcr tert gene mutation testing,pcr thalassemia complete work up,pcr thiopurine toxicity genotyping (tpmt + nudt15 genotyping),pcr thrombophilia mutation,pcr torch panel,pcr toxoplasma detection,pcr tp53 gene mutation analysis,pcr tpmt genotyping,pcr transplant pathogen mini panel a,pcr transplant pathogen mini panel b,pcr transplant pathogen mini panel c,pcr transplant pathogen mini panel d,pcr transplant pathogen panel (13 pathogens),pcr tropical fever panel,pcr ugtia1 mutation,pcr varicella zoster virus,pcr vesicular rash panel,pcr viral meningitis qualitative,pcr warfarin sensitivity,pcr west nile virus detection,pcr y chromosome microdeletion,pcr zika virus rna (qualitative),pcwh syndrome (pcwh),pdgfra mutations,pdl 1 by immunohistochemistry,pediatric hematologic malignancies panel 16 genes,pediatric nervous system/brain tumors panel 32 genes,pediatric solid tumors panel 47 genes,pelizaeus merzbacher disease (pmd),pelizaeus merzbacher like disease gjc2,penicillium chrysogenum specific igg,periodic fever syndromes panel lpin2, mefv, mvk, nlrp3, pst pip1, tnfrsf1a,peripheral smear study,perlman syndrome test dis3l2,pesticide (qualitative) gastric lavage wadaj,peutz jeghers syndrome stk11,ph for fluid,phadia extended eczema panel,phadia extended rhinitis/asthma panel.,phadia generalized comprehensive panel.,phadia non veg. food panel,phadia veg. food panel,phadia comprehensive food panel (veg. and non veg,phadia generalized comprehensive panel.(veg food),phadiatop adult allergy screening,phadiatop infant allergy screening,phadiatop infant( <5 year) ige,phelan mcdermid syndrome,phenobarbitone,phenol level urine,phenothiazines (qualitative) urine,phenylalanine quantitative plasma,phenytoin (eptoin/epsolin/dilantin),pheochromocytoma marker profile,phosphorus,phosphorus 24 hour urine,pigeon serum protein feather & droppings igg,pitt hopkins syndrome (pths),pituitary hormone deficiency, combined, 4 (cphd4),pivka ii,pivka ii (dcp),pla2 receptor ab by elisa,pla2 receptor antibody quantitative,plasma renin activity,platelet count (fluorescent),platelet gp receptor (gpiib/iiia and gp ib) study by flowcytometry,platinum,pleural fluid analysis,pml/rara,pml rara qualitative by real time pcr,pml rara quantification by real time pcr,pneumo slide panel,pneumocystis carinii detection,pneumoslide panel by ifa igm,pnh by flaer method,pnh by flow (flaer),pompe disease test gaa, lamp2,porphobilinogen urine,porphyria profile (porphobillinogen + ala),posaconazole level,potassium (k+),potassium 24 hour urine,potocki lupski syndrome (ptls),potocki shaffer syndrome (pss),prader?willi syndrome (pws),prader willi/angelman syndrome methylation specific deletion/duplication analysis(ms mlpa),pregnancy test ( upt ),pregnenolone,pre implantation genetic screening (1 embryo) extended,pre implantation genetic screening (1 embryo) stat,prenatal dmd (26 exons); with maternal cell contamination analysis,prenatal fish for 13 18 21 x & y abnormalities,prenatal karyotype & fish,prenatal karyotyping,prenatal karyotyping product of conception(poc),prenatal spinal muscular atrophy; with maternal cell contamination analysis,primary ciliary dyskinesia panel 30 genes,pro calcitonin(pct),product of conception fish,product of conception ngs,progesterone,prolactin,propionic acidemia panel pcca, pccb,prostate cancer panel 12 genes,protein 24 hour urine,protein c,protein c deficiency test proc,protein creatinine ratio,protein electrophoresis,protein s deficiency test pros1,protein s(free),protein with a/g ratio,ps for mp,psa (psa free & psa total),psa total,pt (prothrombin time),pt (prothrombin time) & aptt (activated partial thromboplastin time),pth (parathyroid hormone),pthrp parathyroid hormone releated peptide,pulmonary arterial hypertension panel acvrl1, bmpr2, cav1, eng, kcna5, smad9,pulmonary hypertension, primary, 1(pph1),pus routine examination,pyruvate,pyruvate dehydrogenase e1 alpha deficiency (pdhad),quadruple marker,ra factor,rabies virus antibodies,ras family (kras, hras, nras),rbc folic acid,recombinant chromosome 8 syndrome,recql4 related disorders test,reducing substances stool,renal/urinary tract cancer panel 29 genes,respiratory syncytial virus iga,ret ptc rearrangement,reticulocyte count (automated),retinitis pigmentosa 2 (rp2),retinoblastoma test rb1,retinoschisis 1, x linked, juvenile (rs1),rett and angelman syndromes and related disorders panel (upto 26 genes),rett syndrome mecp2,rett syndrome, congenital variant,reverse t3,rft renal function test (urea, creatinine, sodium, potassium, chloride),rh antibody titre,rhabdoid tumor predisposition syndrome panel smarca4, smarcb1,riboflavin transporter deficiency neuronopathy panel (2 genes),rifampicin by hplc,ripa (ristocetin induced platelet aggregation),rna sequencing & analysis on illumina platforms (sample 35),rna seq_db (rna seq genome database),ros 1,rota virus stool,rota virus stool,rpr (vdrl),rubella (german measles) avidity, igg,rubella igg,rubella igm,rubinstein taybi syndrome 1 (rsts1),s.typhi igm by card,saethre chotzen syndrome (scs),sandhoff disease test hexb, hexa,sanger sequencing (sample 44),sanger sequencing (sample 41),sanger sequencing (sample 45),sanger sequencing of amplicons (single direction),sarcoma panel 40 genes,sbb (sudan black b) stain,sca 12,sca 2,sca 3,sca 6,schwannomatosis test smarcb1, nf2,scl 70 antibody,scleroderma diagnosis panel,scrap material c/s,scrub typhus igg by card,scrub typhus igm by card,scrub typhus igm by elisa,seizures, benign familial neonatal, 1, and/or myokymia,selenium level,semen examination,senior loken syndrome panel cep290, iqcb1, nphp1, nphp4,serotonin serum,serum ascites albumin gradient (saag),severe combined immunodeficiency panel 19 genes,sex growth hormone,sex hormone binding globulin (shbg),sgot,sgpt,short qt syndrome panel cacna1c, cacna2d1,)cacnb2, kcnh2, kcnj2, kcnq1,sickle cell disease (targeted) 3 genetic variants,sickle cell disease (targeted) 3 genetic variants; with maternal cell contamination analysis,sickling test,simpson golabi behmel syndrome test gpc3,simpson golabi behmel syndrome, type 1 (sgbs1),single mutation confirmation by sanger sequencing,sirolimus level,skeletal function test,skin dif(direct immunofluorescence (dif),slide for review (>20 slides + >20 blocks),slide for review (1 slide + 1 block),slide for review (10 15 slides + 10 15 blocks),slide for review (16 20 slides + 16 20 blocks),slide for review (2 slides + 2 blocks),slide for review (3 slides + 3 blocks),slide for review (4 to 6 slides + 4 to 6 blocks),slide for review (5 slides + 5 blocks),slide for review (6 slides + 6 blocks),slide for review (7 to 9 slides + 7 to 9 blocks),slit skin smear examination with modifiled acid fast stain,sm ab,small cell carcinoma of the ovary (hypercalcemic type) test smarca4,small fiber neuropathy scn9a, scn10a,smith lemli opitz syndrome (slos),smith magenis syndrome (sms),snp det08 (snp detection in 500 bases),sodium (na+),sodium 24 hour urine,sodium urine,soluble transferrin receptor stfr,somatic mutation panel 56 genes,sotos syndrome 1 (sotos1),sotos syndrome test nsd1,speech language disorder 1 (spch1),sperm dna fragmentation,spermatogenic failure, y linked (spgfy) panel,spinal muscular atrophy by mlpa,spinal muscular atrophy panel (2 genes),split hand/foot malformation (shfm) panel,sputum for afb,sputum for cytology,sputum for eosinophil,sputum routine & micro,ss a by elisa,ss a/ro (60 kda 52 kda),ss a/ro (60 kda),ss b by elisa,ss b/la,stem cell count(cd 34 count),sterility test for biological indicator,sterility test for blood product,sterility test for water,steroid detection in unknown drug powder,stickler syndrome (stl) panel,stone analysis,stone analysis by automated machine,stool antigen h.pylori,stool examination,stool examination for parasite,stool for hanging drop,stool for vibrio cholera,stool occult blood,streprococcus pneumoniae (pneumococcal) ag urine,streptococcus pneumoniae antigen,stress cytogenetic (fanconi anemia),strongyloidiasis serology serum by eia,str plate12 (microsatellite genotyping),str rrp10 (microsatellite genotyping(ready to run)),succinylacetone,succinylacetone, blood,sucrose lysis test,sudan iii stain for fat in stool,sudan iv stain stool,swine flu by pcr,syndromic neurodevelopmental epilepsy panel 16 genes,synovial fluid gram z n stain,synovial fluid routine examination,synovial fluid uric acid,synpolydactyly 1(spd1),syphilis (total) antibodies,syphilis antibody,systemic scierosis profile,t3,t4,tacrolimus level,tamoxifen sensitivity test (cyp2d6 mutations),tay sachs disease mutation analysis hexa,tb gold,tb pcr by gene expert,tb pcr from block,tb pcr from tissue,tb pcr blood,tb pcr csf,tb pcr fluid,tb pcr urine,tel/aml1,testosterone,tetanus toxoid igg antibodies,tft thyroid function test basic (t3, t4, tsh),tft thyroid function test advance (free t3, free t4, tsh),thallium by icpms,theophylline,thiopurine metabolite,thrombin time,thrombocytopenia, paris trousseau type (tcpt),thrombocytopenia absent radius syndrome (tar),thrombophilia panel,thrombophilia panel (mthfr, factor v and factor ii) by pcr,thyroglobulin,thyroid cancer panel 11 genes,thyroid stimulating immunoglobulin (tsi),thyroxine binding globulin (tbg) level serum,timothy syndrome cacna1c (exon 1 is not included in deletion/ duplication analysis),tissue processing block cutting and staining for 1st block & slide,2nd block cutting and slide staining for same patient,extra slide staining (h & e),grossing charges per sample,tissue transglutaminase ttg dgp screen,t lymphocyte subset analysis,tms newborn screening for metabolic disorder,tms extended (new born screening) up to six month,tnf alpha,toe syndactyly, telecanthus, and anogenital and renal malformation,tooth agenesis, selective 3 (sthag3),torch 5 parameters igg,torch 5 parameters igm,torch complex 10 parameter (elisa ),torch complex 8 parameter (elisa),torch panel avidity igg,total bilirubin,total iron binding capacity (tibc),total protein fluid,total protein serum,townes brocks syndrome (tbs),townes brocks syndrome test sall1,toxo igg,toxo igm,toxoplasma avidity, igg, serum,toxoplasma dna detection, pcr,tpha,tpha,csf,tpmt enzyme activity,tpmt genotyping,transferrin level,transferrin saturation,transplant donor derived cell free dna ; % dd cfdna,transplant hla typing (a b c drb1 drb3 4 5 dqab),transplant hla typing (a b drb1),transplant hla typing for patient and donor,transplant hla typing individual locus (a/b/c/dr/dq),transplant lymphocyte cross match report (cdc),transplant panel reactive antibody report (pra) class i & ii report,transplant single antigen screen test (sa qualitative class i ii & mic a),transplant single antigen quantitative test report (single antigen class i & ii ),transplant t & b cell flow cross match (fcxm) report,transthyretin amyloidosis ttr,treacher collins syndrome 1 (tcs1),trichorhinophalangeal syndrome (trps) panel,tricyclic antidepressants (tca),triglyceride,triglyceride fluid,triglyceride urine,triple marker,triple x syndrome,trisomy 12,trisomy 8,troponin t,troponin i (high sensitive) by cmia,troponin i (high sensitive) by clia,tryptase,tsh,tsh receptor antibody,ttg iga,ttg igg,ttg dgp screen test,tuberculosis culture,tuberous sclerosis (tsc) panel,tuberous sclerosis complex panel tsc1, tsc2,turner syndrome,type vi collagenopathy panel col6a1, col6a2, col6a3,typhi dot by card,typhi dot igg,typhi dot igm,u1rnp (rnp) ab,u1 snrnp,uibc,ulnar mammary syndrome (ums),unifungal pcr,uniseq 01 (purified plasmid/pcr product sequencing service),uniseq 02 (r e.coli clone sequencing service),unstable hb,upt (urine pregnancy test),urea,urea clot lysis test,urea cycle disorders panel aldh18a1, arg1, asl, ass1, cp s1, hmgcl, oatotc, slc25a13, slc25a15,urea fluid,urea nitrogen 24 hour urine,uric acid 24 hour urine,uric acid serum,uric acid urine,urine afb,urine albumin,urine amino acid quantitative by lcms,urine calcium,urine calcium creatine ratio,urine chloride,urine copper (spot),urine cotinine (nicotine) level by card,urine cotinine by hplc,urine creatinine (random),urine drug screen amphetamine,urine drug screen barbiturate,urine drug screen benzodiazepine,urine drug screen cocaine/benzoylecgonine,urine drug screen marijuana,urine drug screen methadone,urine drug screen methamphetamine,urine drug screen opiates/morphine,urine drug screen phencyclidine,urine drug screen tetra hydro cannabinol,urine drug screen (6 drugs),urine drug screen (9 drugs),urine electrolytes (random),urine for chyluria,urine for cytology,urine for eosinophil,urine for fat globules,urine for haemoglobinuria,urine for heavy metals,urine for phase contrast microscopy,urine for protein electrophoresis,urine for reducing substances,urine for specific gravity,urine free light chain assay,urine glucose,urine hemosiderin,urine immunofixation,urine kappa light chain,urine magnesium,urine myoglobin,urine organic acid,urine ph,urine phosphorus(random),urine porphobilinogen qualitative,urine porphobillinogen quantitative (24 hour),urine porphobillinogen quantitative (spot),urine potassium,urine protein,urine protein creatinine ratio,urine protein electrophoresis,urine rbc morphology by phase contrasmicroscopy,urine routine examination,urine uric acid,urine uric acid creatinine ratio,urine urobilinogen,valproic acid level (sodium valporate),van der woude syndrome 1 (vws1),van der woude syndrome panel grhl3, irf6,vancomycin,varicella zoster igg,varicella zoster igm,vdrl,vdrl csf,velocardiofacial syndrome (vcfs),vgkc antibody serum,vgkc antibody, csf,vitamin a,vitamin b1,vitamin b12,vitamin b2,vitamin b6 (pyridoxine),vitamin c,vitamin d,vitamin d gold (covers vitamin d2 vitamin d3 & d),vitamin e,vitamin k,vitamin k1,vitek cs blood aerobic with vitek automation,vitek cs csf with vitek automation,vitek identification,vitek identification and sensitivity,vitek sensitivity,vizag one marker,vizag pdl1(b7h1p),vma 24 hour urine,von hippel lindau syndrome vhl by pcr,von willebrand disease (vwd) test,von willebrand factor (vwf) study,von willibrand antigen,voriconazole level,waardenburg syndrome (ws) panel,warfarin sensitivity (cyp2c9, vkorc1),was related disorders test,weak z n stain,weaver syndrome test ezh2,weil felix test,werner syndrome test wrn,wet mount preparation,whole exome sequencing,widal,william syndrome (7q11.23),williams beuren region duplication syndrome,wilms tumor panel dkn1c, dis3l2, gpc3, wt1,wilms tumor, aniridia, genitourinary anomalies and,wilson disease test atp7b,witkop syndrome,wolf hirschhorn syndrome,womens hereditary cancers (hereditary breast and gynecologic cancers) 22 genes,wt1 related disorders test,x, y fish panel,xdr tb rapid genotyping,xdr tb rapid genotyping test 2nd line (aminoglycosides/fluoroquinol ones/capreomycin),xdr tb rapid genotyping test 2nd line (aminoglycosides/fluoroquinolones/capreomycin) lpa,x inactivation, familial skewed,x linked adrenoleukodystrophy (x ald),xpert hcv viral load,xpert hiv viral load,xpert hiv 1 quantitative viral load with cd4 count,xpert xdr tb,y chromosome microdeletion,yersinia culture stool,yersinia enterocolitica antigen stool,zika virus qualitative pcr,zinc level,znt8 (zinc transporter 8) antibody clia...

Gujarat Cancer And Research Institute - Gujarat

33719283 rate contract for purchase of various forms, registers, reports, cards etc. for the year 2022 23 and 2023 24 form 1, form 2, form 3, form 4, form 5, form 6, form 7, form 8, form 9, form 10, form 11, form 13, form 14, form 15, form 16, form 17, form 18, form 19, form 20, form 21, form 22, form 23, form 24, form 25, form 26, form 27, form 28, pre printed a4 half size letter head ( billing stationary ) , pre printed a4 half size letter head ( billing stationary ) , printing of leaflet ( ifc material ) pink pamphlets, gcri annual report, annual report of rural cancer registry ahmedabad district, annual report of population based cancer registry ahmedabad urban agglomeration area, printing of annual statistical reports, gcri annual report, account receipt books, admission book register, blood bank component stock, blood bank blood donation register, blood bank issue register, central sterile supplies dept. exchange books, register 100 pages, register 150 pages, casual leave register, day & night order books., drug issue register, duty list books, expense register, follow up case register, gate pass book, histopathology laboratory registers, immunohisto chemistry entry register, indent book, linen register, neuro admission register, radiotherapy register, repairing slip books, ria lab master register, staff duty book registers., sponge account record forms book, thyroid profile register, operation register, services concession book for patients, log book register for vehicle, travelling expenditure book ( tada ) , token book gcri pm jay yojana discharge, token number book for different colours, tax invoice book, receipt voucher book, death / discharge file handover book, crash cart book, discharge summary book, oncopathology slide / block receipt book, fumigation register, stock register ( ward ) , oxygen pressure checking register, investigation register, glucose strip monitoring register, priscription paper book, operation register, chemotherapy register, “a†/ “b†/ “o†/ “abâ€positive, “a†/ “b†/ “o†/ “abâ€negative, cross matching labels, leuco reduced red cells with additive solutions, whole human blood with cpd a anticoagulant, fresh frozen plasma, platelet concentrate, single donor apherisis platletele, component, blood bank ( transfusion details ) sticker, sticker label for i.v.t.c., numbering sticker label ( histopathology ) sticker, sticker label ( histopathology ) , sticker lable for zebra printer, sero positive plwha sticker, sticker lable with cartridge ribbon, barcoding printer sticker with cartridge, thermal sticker with carbon roll, sticker label iv fluid, biomedical waste sticker in four different colour ( red, blue, b&w, yellow ) , case cards for outside patient ria & nmc cards., cards, ct scan case cards, patient visiting gate pass card 7 day green colour, mri scan case cards, radiotherapy cards in four different ink. ( small ) , radiotherapy record folder in five different colour cards. ( white, green, yellow, blue, pink ) , registration card with plastic cover, donor certificate card ( blood bank ) multi colour, small pocket card blood bank ( blood group card ) , white cover with printing size: 7â€x4â€, white cover with printing size: 11â€x5â€, white cover with printing size:12â€x10â€, x ray envelopes with lamination & printing ( ct scan & x ray ) , x ray envelopes with lamination & printing, x ray envelopes with lamination & printing x ray dept., x ray envelopes with lamination & printing imaging dept., envelop cssd brown, envelop cssd brown, envelop cssd white, envelop cssd brown, computer stationary with one colour logo printed, computer stationary with one colour logo printed, computer stationary with one colour logo printed, computer stationary with one colour logo printed, computer stationary with one colour logo printed, computer stationary with one colour logo printed, computer stationary with one colour logo printed, computer stationary with one colour logo printed, pre printd s.t. concession form, printed continuous case registration record, different type of pre printed letter head., different type of pre printed letter head., different type of pre printed letter head., different type of pre printed letter head., case file, re binding of reports...

Health And Family Welfare Department - Gujarat

33531940 tender for supply of injection – a ( non edl items ) 2022 23 injection a.g.g.s. 10000 unit inj., a.t.s. 10000iu inj., a.t.s. 1500iu inj., a b arte ether 150 mg, acetaminophine 225 mg diclofenac 75mg. inj. 3ml, actinomycin inj. 100ml, actinomycin inj. 3ml, actracurium inj.10 mg / ml 10ml, acyclovir 250 infusion inj. 10ml, adenosine inj. 6mg / 2ml, adrenaline 1 / 1000 inj. amp / vial, albumin 5% inj. 50ml, albumin 5% inj. 100ml, albumin20% 0 ( poorsalt ) inj. 100ml, alfentanyl 500mg / ml inj. 2ml, ameoderone inj. 100mg, amidarone inj. 150mg, amikacin inj. 100mg., amphotericin b lipid complex 10mg / 2ml inj., amphotericin b lipid emulsion inj. 50mg, amphotericin b liposomal inj. 50mg, ampicillin 500mg+ salbectum inj., amrinon 50mg iv inj. 20ml, anticoagulant inj. each ml contains adenoso of heamocoagulas isolated from venom of botropos jararacm of botropos atroxcontaining 0.9% of sodium chloride ip & 5.0% of phenol ip ( as preservative. ) 1 ml, anti diptheria vaccine 10000iu inj., anti rabies serum 1500iu inj., anti d 50mcg inj., anti d 350mcg inj., anti hemophilic factor ( factor viii with vvf stabalization 250 i.u., anti hemophilic factor ( factor viii with vvf stabalization 500 i.u., aprotinin 100000kiu inj. 10 ml, aprotinin 500000kiu inj. 50 ml, artether 60mg / 1ml inj. 1 ml, ascorbic acid 500mg inj., atezolizumab 840mg inj, atezolizumab 1200mg inj, atropine sulphate inj. 10ml, atropine sulphate inj. 100ml, azithromycin inj. 250mg, aztreonam 1gm, b1, b6, b12 inj. 3ml, b1, b6, b12 inj. vial, b12 + folic acid + vit c inj., bacillus clausii spore susp. each 5ml oral sup. cont. spores of polyantibiotics resistant bicillus causii 2 billion excipient. water purified ph. eur 5ml, basiliximab 20mg inj, benzathine penicillin 24lac inj., benzyl penicillin 10 lacs inj., benzyl penicillin 20 lacs inj., betamethasone inj. 4mg, bitrate 2mg / ml inj., bivalirudin inj. 250 mg, bleomycin inj. 250mg, bupivacaine 0.5% inj. 20ml vial, bupivacaine hcl 0.5% heavy 4ml for spinal inj. 4 ml, buprenorphine hcl 0.3 mg / ml. inj. 1 ml / 2 ml, butorphenol 1mg / ml. inj. 2 ml, butorphenol 1mg / ml. inj. 5 ml, caffine citrate 20mg / ml inj. 1ml vial, caffine citrate 20 mg / ml inj. 1.5 ml vial, caffine citrate 20 mg / ml inj. 3ml vial, calcitonin synthetics salmon 100iu inj. vial, calcitonin synthetics salmon 50iu inj. vial, capreomycin inj. 0.75gm., carbenicillin iv inj. 1gm, carboplatin inj. 150mg, carboplatin inj. 450mg, carboprost tromethamine inj. 125mg, carboprost tromethamine inj. 250mg, carborpost trimethamine inj. 250mcg / ml., carborpost trimethamine inj. 125mcg / ml., caspofungin acetate inj. 50 mg vial, caspofungin acetate inj. 70 mg vial, cefazoline sod. inj. 500mg., cefazoline sod. inj. 1gm., cefipime inj. 500mg., cefipime inj. 1gm., cefipime inj. 2gm., cefoperazone inj. 250mg., cefoperazone inj. 500mg., cefoperazone inj. 1gm., cefoperazone inj. 2gm., cefoperazone with salbectum inj. 1gm., cefoperazone with salbectum inj. 2gm., cefpirome inj. 500mg., cefpirome inj. 1gm, ceftazidine inj. 1gm., ceftazidine inj. 2gm., ceftizoxime inj. 500mg., ceftizoxime inj. 1gm., ceftriaoxone with salbectum inj. 750mg, ceftriaoxone with salbectum inj. 1.5gm, ceftriaxone 500mg. + tazobactum 62.5mg inj. vial, ceftriaxone 1gm + tazobactum 125 mg inj. vial, ceftriaxone 2gm + tazobactum 250 mg inj. vial, ceftazidime injection 2.5gm, ceftazidime 2gm and avibacutm 0.5gm vial injection, ceftaroline fosamil 600mg injection, cefuroxime inj. 250mg, cefuroxime inj. 500mg., cefuroxime inj. 750mg, cefuroxime inj. 1.5gm., centbucridine hcl 5 mg methyl paraben ip 0.5 mg inj., cephaloridine inj. 500mg., cestadial valerate inj. 10mg, chloramphenicol sodium succinate iv inj. 1gm, chlorapheniramine 2ml iv inj. 500mg, chloroquine phsphate1gm. i / v inj. 5ml, chlorpromazine 25mg inj. 2 ml, cisplatin inj. 10mg, cisplatin inj. 50mg, cisplatin inj. 100mg, clarithromycin inj. 500mg, clidamycin inj. 600mg., clonidine 150mcg / ml, cloxacillin 250mg. inj. 3 ml, cloxacillin 500mg. inj. 3 ml, colistimethate sodium 10 lac inj., crizanlizumab 100mg inj. 10ml, cyclophosphamide inj. 200mg, cyclophosphamide inj. 500mg, cyclophosphamide inj. 1gm, cynoacrylate ( glue ) inj. 2ml., cytarabin inj. 100mg, cytarabin inj. 500mg, cytarabin inj. 1 gm, deltaparin sodim 500iu inj. 1 ml, deltaparin sodim 10000iu inj. 1 ml, deltaparin sodium 2500iu inj. 0.2 ml, deltaparin sodium 5000iu inj. 0.2 ml, deltaparin sodium 7500iu inj. 0.3 ml, dalteparin mdv 10ml ( 100000iu ) injection, desferrioxamine mesylate injection 500 mg, dexeldefluxisation inj. 1ml, dextrose 25% inj. 2ml, dextrose 50% inj. 2ml, dextrose 50% glass bottle inj. 100ml, destrose 5% with 0.9% sodium chloride inj. 500ml., dextran 150 in dextrose inj. 500ml., dextran 40 in dextrose inj. 500ml., dextrose 10% inj. 500ml., dextrose 10% in invert sugar inj. 500ml., dextrose 25% inj. 100ml., dextrose 5% inj. 500ml., dextrose 50% inj. 100ml., diazepam iv 2ml. inj. 0.75gm., diclofenac sod. iv / im. inj. 3ml., diclofenac sod. 75 mg im. inj. 1ml. ( aquoes ) , diclofenac sod. 75 mg iv inj. 3ml., digoxin 0.5mg inj. 2ml, dimerrcaprol ip 50mg inj. 2ml, distilled water ( 500ml ) , distilled water ( 1000ml ) , doripenum inj., doxapram hcl 20mg / 5ml inj., doxycycline 100mg inj., drotavetrin 40mg inj. 2ml, inj. dulaglutide 0.75 mg, inj. dulaglutide 1.5 mg, dulaglutide 0.75mg injection, elanercept inj. 25mg, elanercept inj. 50mg, emicizumab inj. 30mg, emicizumab inj. 60mg, emicizumab inj. 105mg, emicizumab inj. 150mg, enalaprilat inj. 1.25mg / ml, enoxaparin inj. 20mg., enoxaparin 40mg. inj. 40mg, epoetin beta 2000iu, epoetin beta 5000iu, ephedrin hcl 30mg / ml. inj. 1 ml, ertapenem sodium inj. 1gm, erythropoitene 2000iu inj., erythropoitene 3000iu inj., erythropoitene 4000iu inj., esmolol hcl 100mg / 10ml. inj. 10 ml, esomeprazole inj. 20mg, etanercept 50 mg â injection, etanercept 25mg injection, ethacridine lactate inj. 50ml, ethamsylate inj. 1mg., etomidate lipuro 2mg / ml inj. 10ml, fenopenam inj. 100mg., fenopenam inj. 200mg., fibrin hemostatic solution inj. 2ml, folicle stimulating hormone inj. 75iu, folicle stimulating hormone inj. 150iu, folinic acid 15mg / ml. inj., fluconazole 100ml i.v. inj., gammaglobuline 16.5% im inj., ganciclovir 500mg inj., gatifloxacin 400mg. / 200ml. inj. 200 ml, gensparin sodium inj. 0.2ml, gensparin sodium inj. 0.4ml, gensparin sodium inj. 0.6ml, gensparin sodium inj. 10ml., glycopyrrolate 0.2mg. / ml. inj. 1 ml, glycopyrrolate 0.2mg. / ml. inj. 10 ml, gonadotropin release hormone analogue / agonist, granisetrone 1mg / ml inj. 3ml vail, heloperidol 50mg. inj. 1 ml, haloperidol deconate 50mg / ml. inj., hemofilous influanzae b vaccine vial, heparine 25000 iu / 5ml. inj. 5 ml, hepatitis a vaccine inj. 720eu, hepatitis a vaccine inj. 1440eu, hepatitis b immunoglobuline human 100iu inj. 0.5ml, hepatitis b immunoglobuline human 200iu inj. 1ml, hib vaccine, human chorionic gondotrophins inj. 2500iu, human chorionic gondotrophins inj. 5000iu, human chorionic gondotrophins inj. 10000iu, human cried fibrinogen with dilaqnt ( d.w. ) inj. 1000ml, human growth hormon inj. 30 iu, human hepatitis b immunoglobulin for intramuscular 180 i.u. / 1ml, human hepatitis b immunoglobulin for intramuscular 540 i.u. / 1ml, human immunoglobuline tatanus inj. 500iu, human immunoglobuline tatanus inj. 1000iu, human menopousal gondotrophins inj. 75iu, human menopousal gondotrophins inj. 150iu, human normal immunoglobuline ( ivig 100 mg / ml solution for infusion ( 10% ) inj. 1gm, human peppiloma virus vaccine inj., hydralazine hydrochloride inj. 20 mg, hydrocortisone acetate inj. 100mg., hydrocotrisone succinate inj. 100mg, hydroxy progesterone caproate inj. 250mg., hydroxy progesterone caproate inj. 500mg., hydroxyethyl starch 6% w / v m.wt 450000 inj. 500ml, hylam g f 20 each 1ml cont. hylam polymer 8.0mg, sodium chloride 8.5mg, disodium hydrogen phosphate 0.16mg. sodium dihydrogen phosphate hydratr 0.04mg. water for injection, hypiomellose inj. 500ml, iron ( iii ) isomaltoside 1000 injection 5ml vial, imipenem 250mg & cilastatin sodium 250mg usp inj. vial, imipenem 500mg & cilastatin sodium 500mg usp inj. vial, immunogamma globuline i.v.use. inj. 1gm, immunogamma globuline i.v.use. inj. 1.25gm, immunogamma globuline i.v.use. inj. 2.5gm, immunogamma globuline i.v.use. inj. 5gm, immunogamma globuline i.v.use. inj. 10gm, immunogamma globuline i.v.use. inj. 20gm, influenza virus vaccine. inj. amp., insulin lispro contains: 200 iu / ml injection, insulin aspart ( r dna origin ) 100 iu / ml in 3.0 ml cartridges, insulin degludec / insulin aspart ( 70% / 30% ) 100 iu / ml in 3.0 ml, insulin glargine 100u / ml. inj. 10ml vial, insulin lente 40unit / ml. inj. 10ml.vial, insulin lispro 100u / ml. inj. 10ml.vial, insulin mixtard.100unit.ml. inj. 10ml.vial, insulin plain 40unit / ml inj. 10ml.vial, insulinhumanactrapid inj. 10ml.vial, insulin – r inj. 10ml, intravenous caffine injection vial 100mg, intravenous caffine injection vial 400mg, intravenous caffine injection vial 500mg, intravenous immunoglobulin igm, igg, iga concentrate 10ml vial, interferon 3 miu inj. vial, interferon 5miu inj. vial, interferon alpha2b 18 miu multidose pen, iron dextran iv inj. 10ml, iron sucrose 2.5 ml / 50 mg, iron sucrose 5 ml / 100 mg, isoprenaline inj. 2 ml, isoprinaline sulphate inj., isoxuprine hcl inj. 10 mg, itolizumeb inj., kenamycin sulphate inj. 0.75mg., ketamine hcl 10mg. inj. 10mg, ketamine hcl 50mg. inj. 50mg., ketoralactromethamine inj. 30mg, labetalol inj. 20mg ( 5mg / ml ) , lectysyn oral amp. inj. 10000 spores, leucovorin inj. 2mg, leuprolide acetate depot inj. 3.75mg, leuprolide acetate depot inj. 11.25mg, levofloxacin inj. 750mg / 100ml, levetiracetam inj. 500mg, liganocaine 5% heavy 2ml for spinal inj. 2 ml, lignocaine 2% with adrenaline inj. 30ml, lignocaine hydrochloride and adrenaline bitartrate inj. 30cc, lignocaine hcl 2% for local infiltration inj. 30ml, lignocain 2% preservative free, lignocaine hcl 21.3mg / ml. inj. 30ml., liraglutide injection 18 mg / 3ml, lincomycine 300mg / ml.2ml, , inj. 2 ml, linezolid inj. 100mg, linezolid inj. 200mg, linozolid inj. 300mg, linozolid inj. 600mg, low molecular weight heparin 3200 i.u. inj. 0.6ml, recombinant factor ix long acting 1000 iu inj., recombinant factor ix long acting 2000 iu inj., recombinant factor ix long acting 500 iu inj., recombinant factor viii long acting 1000 iu ( pegylated ) inj., recombinantfactor viii long acting 1500 iu ( pegylated ) inj., recombinant factor viii long acting 2000 iu ( pegylated ) inj., recombinant factor viii long acting 500 iu ( pegylated ) inj., recombinant human growth hormone 36 i.u. injection, l omithine l aspartate 5 gms amp, magnesium sulphate 25% w / v inj. amp., maningococcal vaccine vial, maningococcal vaccine acwy inj. 0.5 ml amp, medroxy progesteron acetate depot 150mg / ml. inj. 3 ml, mephentermine inj. 1 ml amp, mephentermine 30mg / ml. inj. 10ml, meropenum 1gm. iv inj. vial, meropenum 500mg.iv inj. vial, mesna inj. 60mg., methocarbamol 10mg / ml. inj. 2ml, methoxy polyethylene glycol epoetin beta 50 mcg / pfs, methoxy polyethylene glycol epoetin beta 75 mcg / pfs, methoxy polyethylene glycol epoetin beta 100 mcg / pfs, methyl prednisolone acetate inj. 80mg., methyl prednisolone acetate inj. 40mg., methyl prednisolone succinate inj. 40mg., methyl prednisolone succinate inj. 500mg., methyl prednisolone succinate inj. 1gm, methylcobalamine + b1 +b6+d penthonate +nicotinamide inj. vial, methyllene blue 1% iv inj., methylprednisolone succinate inj. 125mg., metoprolol inj. 25mg, micafungin 50mg inj., midazolam hcl 5mg / ml inj. 1ml, midazolam hcl 5mg / ml ( preservative free ) inj. 1ml, midazolam hcl 5mg / ml inj. 10ml, mivacurium inj., mixogen inj, milrinone 10mg=10ml, morphine sulphate15mg / ml. inj. 1ml., n acetyl cystine 2ml inj., nadroparin 10000 axa / 10ml. inj. 10 ml, nadroparin calcium 6000 axa i.u. inj. 0.6 ml, nadroparin calcium 4000 axa i.u. inj. 0.4 ml, nadroparine calcium 0.6ml 11400 iu antixa. inj. 0.6 ml, nalbuphine inj., nandrolone deaconate inj. 25 mg, nandrolone deaconate inj. 50 mg, nandrolone deaconate inj. 100 mg, neloxone hcl 20mcg. inj. 2 ml, neloxone hcl 40mcg / ml. inj. 1 ml, neo stigmin 0.5mg / ml. inj. 5ml., neostigmin 2.5mg +glycopyrrolate 0.5mg.inj. 5ml, netilmycin 10mg. inj. 1 ml, netilmycin 50mg. inj. 2 ml, netilmycin 100mg. inj. 3 ml, netilmycin 200mg. inj. 2 ml, netilmycin 25mg. inj. 1ml, netilmycin 300mg. inj. 3 ml, nikethamide inj. 2 ml, nitroglycerin 25mg / ml. inj. 10ml, nitroglycerin 25mg / ml inj. 5 ml, noradrinaline inj. 4mg....

Gujarat Cancer And Research Institute - Gujarat

33036807 rate contract for purchase of various forms, registers, reports, cards etc. for the year2022 23 and 2023 24 form 1,form 2,form 3,form 4,form 5,form 6,form 7,form 8,form 9,form 10,form 11,form 12,form 13,form 14,form 15,form 16,form 17,form 18,form 19,form 20,form 21,pre printed a4 half size letter head (billing stationary),pre printed a4 half size letter head (billing stationary),printing of leaflet (ifc material) pink pamphlets,gcri annual report,annual report of rural cancer registry ahmedabad district,annual report of population based cancer registry ahmedabad urban agglomeration area,printing of annual statistical reports,gcri annual report,account receipt books 4 " x 7 ½ " 100 set,registers 13" x 16 " 500,registers 13" x 16 " 500,registers 13" x 16" 400,registers 13" x 16" 400,registers 13" x 16" 300,registers 13" x 16" 300,registers 13" x 16" 200,registers 13" x 16" 200,registers 13" x 16" 100,registers 13" x 16" 100,registers 15" x 10" 200,registers 15 " x 20 " 200,register 15 "x 20 " 250,central sterile supplies dept. exchange books 5 ½ " x 8 ½ " 100 set,registers 20 " x 30 " 160,duty list books 8 ½ " x 13 ",register 13" x 16" a to z index 300,gate pass book 5 "x 7 ½" three colour,registers 16 "x 26 " 250,indent book,linen register 13" x 17" 250,neuro admission register 13 x 17 200,repairing slip books 5†x 7 ½ 100 set,sponge account record forms book 8 ½â€ x 8†200,request for advance 11"x7.5" 100,register 16.5"x27†500,register 16.5"x27†500,services concession book for patients 6½" x 7½" 100 set,log book register for vehicle,travelling expenditure book (tada) 12" x 8.5" 100+100,token book gcri pm jay yojana discharge 6"x4" no.1 to 140 no,token number book for different colours 6"x4" no.1 to 100 no,tax invoice book 12" x 8.5" (2+1) 100 page,receipt voucher book 12" x 8.5" (1+1) 100,death/dishcharge file handover book 12 ½ " x 16 " 1 to 250 single,crash cart book legal size 90,discharge summary book,oncopathology slide/ block recipt book 4â€x7 ½" 100+100,priscription paper book 8.5" x 5.5" 1+1=200,“aâ€/ “bâ€/ “oâ€/“abâ€positive,“aâ€/ “bâ€/ “oâ€/“abâ€negative,cross matching labels,leuco reduced red cells with additive solutions,whole human blood with cpd a anticoagulant,fresh frozen plasma,platelet concentrate,single donor apherisis platletele,component,blood bank (transfusion details) sticker,sticker label for i.v.t.c.,numbering sticker label (histopathology) sticker,sticker label (histopathology),sero positive plwha sticker,biomedical waste sticker in four different colour (red,blue,b&w,yellow),case cards for outside patient ria & nmc cards.,cards,ct scan case cards,patient visiting gate pass card 7 day green colour,mri scan case cards,radiotherapy cards in four different ink.(small),radiotherapy record folder in five different colour cards. (white,green,yellow,blue,pink),registration card with plastic cover,donor certificate card (blood bank) multi colour,small pocket card blood bank (blood group card),white cover with printing size: 7â€x4â€,white cover with printing size: 11â€x5â€,white cover with printing size:12â€x10â€,x ray envelopes with lamination & printing (ct scan & x ray),x ray envelopes with lamination & printing,x ray envelopes with lamination & printing x ray dept.,x ray envelopes with lamination & printing imaging dept.,envelop cssd brown,envelop cssd brown,envelop cssd white,envelop cssd brown,computer stationary with one colour logo printed,computer stationary with one colour logo printed,computer stationary with one colour logo printed,computer stationary with one colour logo printed,computer stationary with one colour logo printed,computer stationary with one colour logo printed,computer stationary with one colour logo printed,computer stationary with one colour logo printed,pre printd s.t. concession form,printed continuous case registration record,different type of pre printed letter head.,different type of pre printed letter head.,different type of pre printed letter head.,different type of pre printed letter head.,case file,re binding of reports...

Civil Hospital - Gujarat

33035130 supply of laboratory equipments ihbt 1 anti a • monoclonal antisera formulated cell culture supernatant containing murine igm anti a, suitable for slide, tube and plates.• a blend of monoclonal antibodies.• potency, specificity and avidity shall be as per the criteria of dghs 2003.• should preferably detect common weaker variants. • reagent to be suitable for slide, tube and micro plate assay• packed in 10 ml vial. 2 anti a • monoclonal antisera formulated cell culture supernatant containing murine igm anti a, suitable for slide, tube and plates.• a blend of monoclonal antibodies.• potency, specificity and avidity shall be as per the criteria of dghs 2003.• should preferably detect common weaker variants. • reagent to be suitable for slide, tube and micro plate assay• packed in 5 ml vial. 3 anti b • monoclonal antisera formulated cell culture supernatant containing murine igm anti b, suitable for slide, tube and plates.• a blend of monoclonal antibodies.• potency, specificity and avidity shall be as per the criteria of dghs 2003.• should preferably detect common weaker variants. • reagent to be suitable for slide, tube and micro plate assay• packed in 10 ml vial. 4 anti b • monoclonal antisera formulated cell culture supernatant containing murine igm anti b, suitable for slide, tube and plates.• a blend of monoclonal antibodies.• potency, specificity and avidity shall be as per the criteria of dghs 2003. • should preferably detect common weaker variants. • reagent to be suitable for slide, tube and micro plate assay• packed in 5 ml vial. 5 anti ab • monoclonal antisera formulated cell culture supernatant containing murine igm anti ab suitable for slide, tube and plates.• a blend of monoclonal antibodies.• potency, specificity and avidity shall be as per the criteria of dghs 2003.• should preferably detect common weaker variants. • reagent to be suitable for slide, tube and micro plate assay• packed in 10 ml vial. 6 anti ab • monoclonal antisera formulated cell culture supernatant containing murine igm anti ab suitable for slide, tube and plates.• a blend of monoclonal antibodies.• potency, specificity and avidity shall be as per the criteria of dghs 2003.• should preferably detect common weaker variants. • reagent to be suitable for slide, tube and micro plate assay• packed in 5 ml vial. 7 anti d • monoclonal antisera formulated cell culture supernatant containing human igm anti d antibodies• reagent to be suitable for slide, tube and micro plate assay• potency, specificity and avidity shall be as per the criteria of dghs 2003 • should preferably detect common d variants. • packed in 5 ml vial. 8 anti d • monoclonal antisera formulated cell culture supernatant containing human igm anti d antibodies• reagent to be suitable for slide, tube and micro plate assay• potency, specificity and avidity shall be as per the criteria of dghs 2003 • should preferably detect common d variants. • packed in 10 ml vial. 9 anti d • monoclonal antisera formulated cell culture supernatant containing human igg anti d antibodies• reagent to be suitable for slide, tube and micro plate assay• potency, specificity and avidity shall be as per the criteria of dghs 2003 • should preferably detect common d variants. • packed in 5 ml vial. 10 anti d •polyclonal antisera formulated cell culture supernatant containing human blend igg + igm anti d antibodies• reagent to be suitable for slide, tube and micro plate assay• potency, specificity and avidity shall be as per the criteria of dghs 2003 • should preferably detect common d variants. • packed in 10 ml vial. 11 anti a 1 • should be either lectin obtained from dolicus biflorus diluted in buffered saline or polyclonal / monoclonal antiserum• neutral ph• ready to use• should differentiate clearly between a1 and a2 as well as a1b and a2b• reagent to be suitable for slide, tube and micro plate assay• potency, specificity and avidity shall be as per the criteria of dghs 2003 • packed in 5ml vial. 12 anti a 1 •should be either lectin obtained from dolicus biflorus diluted in buffered saline or polyclonal / monoclonal antiserum• neutral ph• ready to use• should differentiate clearly between a1 and a2 as well as a1b and a2b• reagent to be suitable for slide, tube and micro plate assay• potency, specificity and avidity shall be as per the criteria of dghs 2003 • packed in 10 ml vial. 13 anti h • should be either lectin obtained from ulex europeus diluted in buffered saline or polyclonal / monoclonal antiserum• neutral ph• ready to use• should recognize “h†antigen on all human red cells• should differentiate clearly between “bombay phenotype†(oh] and others.• reagent to be suitable for slide, tube and micro plate assay• potency, specificity and avidity shall be as per the criteria of dghs 2003 • packed in 5 ml vial. 14 anti h • should be either lectin obtained from ulex europeus diluted in buffered saline or polyclonal / monoclonal antiserum• neutral ph• ready to use• should recognize “h†antigen on all human red cells• should differentiate clearly between “bombay phenotype†(oh] and others.• reagent to be suitable for slide, tube and micro plate assay• potency, specificity and avidity shall be as per the criteria of dghs 2003 • packed in 10 ml vial. 15 anti human globulin • polyspecific anti human globulin prepared from a pool of rabbit anti igg serum and mouse monoclonal anti c3b and anti c3d.• should be a blend of polyspecific rabbit anti human igg and murine monoclonal anti c3b and c3d antibodies.• should be for the detection of cell bound blood group antibody and/or components of complement based on direct antiglobulin test and indirect antiglobulin test.• potency and specificity shall be as per the criteria of dghs 2003 • packed in 5ml vial. 16 anti human globulin • polyspecific anti human globulin prepared from a pool of rabbit anti igg serum and mouse monoclonal anti c3b and anti c3d.• should be a blend of polyspecific rabbit anti human igg and murine monoclonal anti c3b and c3d antibodies.• should be for the detection of cell bound blood group antibody and/or components of complement based on direct antiglobulin test and indirect antiglobulin test.•potency and specificity shall be as per the criteria of dghs 2003. • packed in 10 ml vial. 17 anti human globulin •monospecific anti human globulin prepared from a pool of rabbit anti igg serum .• should be monospecific rabbit anti human igg .• should be for the detection of cell bound blood group antibody based on direct antiglobulin test and indirect antiglobulin test.•potency and specificity shall be as per the criteria of dghs 2003. • packed in 10 ml vial. 18 anti human globulin •monospecific anti human globulin prepared from a pool of rabbit anti c3 serum .• should be monospecific rabbit anti human c3.• should be for the detection of cell bound blood group antibody based on direct antiglobulin test and indirect antiglobulin test.• potency and specificity shall be as per the criteria of dghs 2003.• packed in 10 ml vial. 19 22% bovine albumin • suitable for enhancement of red cell agglutination reactions.• should be derived from raw bovine serum.• protein concentration should be 22%• should be free from potential infectious risk as the source is bovine serum.• the ph should be neutral.• should be suitable for use with direct as well as indirect agglutination tests.• the conductivity should be controlled for serological applications• packed in 10 ml vial• storage temperature should be 2+ to 8+oc 20 22% bovine albumin •suitable for enhancement of red cell agglutination reactions• should be derived from raw bovine serum• protein concentration should be 22%• should be free from potential infectious risk as the source is bovine serum • the ph should be neutral• should be suitable for use with direct as well as indirect agglutination tests.• the conductivity should be controlled for serological applications• packed in 5 ml • storage temperature should be 2+ to 8+oc 21 anti c antisera monoclonal igm antibodies ,liquid, ready to use in 5ml vials preservative: <0.1% nan3 cell line: ms 24 22 anti c antisera monoclonal igm antibodies ,liquid, ready to use in 10ml vials preservative: <0.1% nan3 cell line: ms 24 23 anti c antisera monoclonal igm antibodies ,liquid, ready to use in 5ml vials preservative: <0.1% nan3 cell line: ms 33 24 anti c antisera monoclonal igm antibodies ,liquid, ready to use in 10ml vials preservative: <0.1% nan3 cell line: ms 33 25 anti e antisera monoclonal igm antibodies ,liquid, ready to use in 5ml vials preservative: <0.1% nan3 cell line: ms 260 26 anti e antisera monoclonal igm antibodies ,liquid, ready to use in 10ml vials preservative: <0.1% nan3 cell line: ms 260 27 anti e antisera monoclonal igm antibodies ,liquid, ready to use in 5ml vials preservative: <0.1% nan3 cell line: ms 16, ms 21, ms 63 28 anti e antisera monoclonal igm antibodies ,liquid, ready to use in 10ml vials preservative: <0.1% nan3 cell line: ms 16, ms 21, ms 63 29 anti fya antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 30 anti fyb antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 31 anti lea antisera igm class antibody, ready to use in 2ml vial preservative: <0.1% nan3 32 anti leb antisera igm class antibody, ready to use in 2ml vial preservative: <0.1% nan3 33 anti lua antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 34 anti lub antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 35 anti p antisera monoclonal igm antibodies ,liquid,ready to use in 1ml vials preservative: <0.1% nan3 , cell line 650 36 anti k, antisera igm class antibody, ready to use in 5ml vial preservative: <0.1% nan3 37 anti k antisera igm class antibody, ready to use in 2ml vial preservative: <0.1% nan3 38 antikpa antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 39 antikpb antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 40 anti s antisera igm class antibody, ready to use in1ml vial preservative: <0.1% nan3 41 anti s antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 42 anti m antisera monoclonal antibodies (mouse hybridoma),liquid, ready to use in 2 ml vials preservative: <0.1% nan3 43 anti n antisera monoclonal antibodies (mouse hybridoma),liquid,ready to use in 2 ml vials preservative: <0.1% nan3 44 anti jsa antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 45 anti jsb antisera igm class antibody, ready to use in 1ml vial preservative: <0.1% nan3 46 anti jka antisera igm class antibody, cell line:ms 15, ready to use in 2ml vial preservative: <0.1% nan3 47 anti jkb antisera igm class antibody, cell line:ms 15, ready to use in 2ml vial preservative: <0.1% nan3 48 anti cde antisera monoclonal igm antibodies ,liquid, ready to use in 5ml vials preservative: <0.1% nan3 49 anti cde antisera monoclonal igm antibodies ,liquid, ready to use in 10ml vials preservative: <0.1% nan3 cell line: ms 26,ms 201,ms 80 50 coombs control cells coombs control igg , red cell sensitised with igg, in a 4%+/ 1% suspension, ready to use, in 10 ml vials. 51 acid elution kit • for rapid acid elution of antibodies from intact rbcs.• containing wash solution (concentrated) containing glycine nacl buffer, elution solution containing a low ph glycine buffer with colour indicator in 10 ml vial. buffer solution containing tris buffer with bovine albumin(1 2%) in 10 ml vial.storage temperature of kit : 2 8 0 c.• shelf life : 1 year 52 edta glycine elution kit •for elution of igg from rbcs.•the kit should contain concentrated solution of sodium edta, low ph glycine solution, tris(hydroxymethyl) aminomethane solution.•storage temperature of kit : 2 8 0 c.•shelf life : 1 year 53 adsorption kit for warm autoantibody •should remove warm reactive autoantibody from red blood cells to facilitate resolution of serological complexities.•the reagent is based on the zzap reagent.•should have lyophilized dithiothreitol and cysteine activated papain in a phosphate buffer.•50 or 100 tests/ kit.•shelf life of reconstituted reagent should be at least 5 days. •storage temperature of kit : 2 8 0 c.•shelf life : 1 year 54 adsorption kit for cold autoagglutinins •should use rabbit erythrocyte stroma for adsorption of cold agglutinins anti i, anti h or anti ih.•should contains a saline suspension of rabbit erythrocyte stroma for autoadsorption of cold autoagglutinin.•should have long expiry and stability. 55 duolys (diagast qwalys 3) with free supply of required quality controls hema cqi for qwalys diagast test compatible on qwalys diagast microplate should have (anti a, anti b, anti ab, anti d, anti e, anti e, anti c, anti c, anti kell, neg control, a1, b (cells) including all reagent use in this test. 56 crosslys (diagast qwalys 3) test compatible on qwalys diagast microplate should have ( igg/c3d/clt) including all reagent use in this test. 57 screenlys (diagast qwalys 3) test compatible on qwalys diagast 11 cell panel for antibody identification including all reagent use in this test. 58 abdlys(diagast qwalys 3) with free supply of required quality controls hema cqi for qwalys diagast test compatible on qwalys diagast microplate should have (anti a, anti b, anti d, neg control, a1, b (cells) including all reagent use in this test. 59 groupa2lys (diagast –qwalys 3) with free supply of required quality controls hema cqi for qwalys diagast test compatible on qwalys diagast microplate should have (anti a, anti b, anti ab, anti d1, anti d2, neg control, a1,a2, b,o (cells) including all reagent use in this test. 60 crosslys (diagast qwalys 3) test compatible on qwalys diagast microplate for cross matching including all reagent use in this test. 61 screenlys (diagast qwalys 3) with free supply of required quality controls sera cqi for qwalys diagast •test compatible on qwalys diagast microplate for antibody screening testing including all reagent use in this test. 62 abd pad device for blood grouping • for performing blood grouping test within 30 40 seconds.• use of patented m trap technology. • ce mark product and approved by nib. • use of whole blood, finger prick, samples drawn in edta, citrate, blood bag segments, • 5 70µl of rbcs can be used per well, no volume specific,• pre dispensed monoclonal antibodies on the device.• can be used up to 37 degree c and 90 % humidity.• no risk of contamination between samples, results. • pre dispensed monoclonal antibodies on the device. •. multipletests per single pad.• expiry 1 to 6 months 63 column agglutination test consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 sii •column agglutination test, required for pre transfusion testing coombs, iat & dat with anti igg , & anti c3 compatible with bio rad gel card incubator 37 si and bio rad gel card centrifuge 12 sii.•the test system shall have required consumables like liss solution and other reagents, dispensers for test. •the test system should be compatible with equipment technology & reagents. •the test system should have facility to perform antibody screening three cell panel, and antibody identification eleven cell panel & cross match.•the reagent red cell panels for antibody screening & identification should be available with the company.•all media and consumables for setting up and standardization should be provided free of cost. •shelf life : minimum 12 months. 64 column agglutination antibody screening consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 sii •the test system should be based on the principle of column agglutination technology compatible with bio rad gel card incubator 37 si and bio rad gel card centrifuge 12 sii.•the test system should able to detect igm, igg, iga, c3c, c3d components.•the test system should be coated with appropriate monospecific antisera for the detection of unexpected antibody eg. anti igm, anti igg, anti iga, anti c3c, anti c3d.•the test system should be supplied with accessories required to perform the test.•shelf life : minimum 12 months. 65 column agglutination test consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 sii •column agglutination test, required for determination of the abo/rh blood grouping combined with reverse grouping and compatible with bio rad gel card incubator 37 si and bio rad gel card centrifuge 12 sii.•the test system shall have required consumables like liss solution and other reagents, dispensers for test. •the test system should be compatible with equipment technology & reagents. •the test system should have monoclonal anti a, anti b, anti d(dvi ), control and a1 and b cell.•the reagent red cell panels for antibody screening & identification should be available with the company.•all media and consumables for setting up and standardization should be provided free of cost. •shelf life : minimum 12 months. 66 column agglutination test consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 sii •column agglutination test, required for determination of the antigen profile for p1, lea, leb, lua, lub and control and compatible with bio rad gel card incubator 37 si and bio rad gel card centrifuge 12 sii.•the test system shall have required consumables like liss solution and other reagents, dispensers for test. •the test system should be compatible with equipment technology & reagents. •the test system should have monoclonal anti p1, anti lea, anti leb, anti lua, anti lub, control.•the reagent red cell panels for antibody screening & identification should be available with the company.•all media and consumables for setting up and standardization should be provided free of cost. •shelf life : minimum 12 months. 67 column agglutination test consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 sii •column agglutination test, required for determination of the antigen profile for k, kpa, kpb, jka, jkb and control and compatible with bio rad gel card incubator 37 si and bio rad gel card centrifuge 12 sii.•the test system shall have required consumables like liss solution and other reagents, dispensers for test. •the test system should be compatible with equipment technology & reagents. •the test system should have monoclonal anti k, anti kpa, anti kpb, anti jka, anti jkb, control.•the reagent red cell panels for antibody screening & identification should be available with the company.•all media and consumables for setting up and standardization should be provided free of cost. •shelf life : minimum 12 months. 68 column agglutination test consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 sii •column agglutination test, required for determination of the antigen profile for m, n, s, s, fya, fyb and control and compatible with bio rad gel card incubator 37 si and bio rad gel card centrifuge 12 sii.•the test system shall have required consumables like liss solution and other reagents, dispensers for test. •the test system should be compatible with equipment technology & reagents. •the test system should have monoclonal anti m, anti n, anti s, anti s, anti fya, and anti fyb.•the reagent red cell panels for antibody screening & identification should be available with the company.•all media and consumables for setting up and standardization should be provided free of cost. •shelf life : minimum 12 months. 69 column agglutination test consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 sii •column agglutination test, required for determination of the rh subgroup and k and compatible with bio rad gel card incubator 37 si and bio rad gel card centrifuge 12 sii.•the test system shall have required consumables like liss solution and other reagents, dispensers for test. •the test system should be compatible with equipment technology & reagents. •the test system should have monoclonal anti c, anti c, anti e, anti e, anti k, control.•the reagent red cell panels for antibody screening & identification should be available with the company.•all media and consumables for setting up and standardization should be provided free of cost. •shelf life : minimum 12 months. 70 column agglutination antibody screening two cell panel consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 •for antibody screening containing 2 cells panel i,ii and should be compatible with bio rad gel card, bio rad incubator 37 si and bio rad gel card centrifuge 12 sii. • should be able to screen all clinically significant antibodies against antigen system of rh, kell, duffy, mns & s & pi, lutheran, kidd, lewis, xg . •medium reagent red blood cells suspended in isotonic medium (red cell preserving solution) •stability at least six weeks (42 days)•storage 2 – 8° c 71 column agglutination antibody screening three cell panel consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 •for antibody screening containing 3 cells panel i,ii,iii and should be compatible with bio rad gel card, bio rad incubator 37 si and bio rad gel card centrifuge 12 sii. • should be able to screen all clinically significant antibodies against antigen system of rh, kell, duffy, mns & s & pi, lutheran, kidd, lewis, xg . •medium reagent red blood cells suspended in isotonic medium (red cell preserving solution)•stability atleast six weeks (42 days)•storage 2 – 8° c 72 column agglutination antibody identification eleven cell panel consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 for antibody identification containing elevan cell panel of 3% reagent red blood cells for anti human globulin procedures (igg detection) & neutral gel (igm detection) compatible with bio rad gel card, bio rad incubator 37 si and bio rad gel card centrifuge 12 sii.•concentration 3% reagent red blood cells comprise of human erythrocytes of group o cells,•should be able to identify all clinically significant antibodies against all clinically significant antibodies.•antigens of rh, kell, duffy, mns & s & pi, lutheran, kidd, lewis, xg blood group system should be present on panel cells.•medium reagent red blood cells suspended in isotonic medium (red cell preserving solution)•stability atleast six weeks (42 days)•storage 2 – 8° c 73 column agglutination antibody identification twenty cell panel consumable compatible for semi automated bio rad incubator37 si and centrifuge 12 •for antibody identification containing twenty cell panel of 3% reagent red blood cells for anti human globulin procedures (igg detection) & neutral gel (igm detection) compatible with bio rad gel card, bio rad incubator 37 si and bio rad gel card centrifuge 12 sii.•concentration 3% reagent red blood cells comprise of human erythrocytes of group o cells,•should be able to identify all clinically significant antibodies against all clinically significant antigens.•antigens of rh, kell, duffy, mns & s & pi, lutheran, kidd, lewis, xg blood group system should be present on panel cells.•medium reagent red blood cells suspended in isotonic medium (red cell preserving solution)•stability atleast six weeks (42 days)•storage 2 – 8° c 74 antibody screening three cell panel consumable based on solid phase red cell adherence technology •for antibody screening containing 3 cells panel i,ii,iii based on solid phase red cell adherence technology • should be able to screen all clinically significant antibodies against antigen system of rh, kell, duffy, mns & s & pi, lutheran, kidd, lewis, xg . •medium reagent red blood cells suspended in isotonic medium (red cell preserving solution)•stability atleast six weeks (42 days)•storage 2 – 8° c• all media, equipment and consumables for setting up and standardization should be provided free of cost. 75 antibody identification fourteen cell panel consumable based on solid phase red cell adherence technology •for antibody identification containing forteen cell panel of 3% reagent red blood cells for anti human globulin procedures based on solid phase red cell adherence technology•concentration 3% reagent red blood cells comprise of human erythrocytes of group o cells,•should be able to identify all clinically significant antibodies against all clinically significant antigens.•antigens of rh, kell, duffy, mns & s & pi, lutheran, kidd, lewis, xg blood group system should be present on panel cells.•medium reagent red blood cells suspended in isotonic medium (red cell preserving solution)•stability atleast six weeks (42 days)•storage 2 – 8° c •all media and consumables for setting up and standardization should be provided free of cost. 76 antibody identification twenty cell panel consumable based on solid phase red cell adherence technology •for antibody identification containing twenty cell panel of 3% reagent red blood cells for anti human globulin procedures based on solid phase red cell adherence technology•concentration 3% reagent red blood cells comprise of human erythrocytes of group o cells,•should be able to identify all clinically significant antibodies against all clinically significant antigens.•antigens of rh, kell, duffy, mns & s & pi, lutheran, kidd, lewis, xg blood group system should be present on panel cells.•medium reagent red blood cells suspended in isotonic medium (red cell preserving solution)•stability atleast six weeks (42 days)•storage 2 – 8° c •all media and consumables for setting up and standardization should be provided free of cost. 77 hbsag elisa test kits • should be third generation elisa kit.• the kit should be based on “sandwich†principle of enzyme linked immunosorbent assay (elisa) for the detection of hepatitis b surface antigen (hbsag) in human serum or plasma. • should detect all known subtypes like ayw1, ayw2, ayw3, ayw4, ayw5, ayr, adw2, adw4, adr and mutant strains.• should have monoclonal antibodies on solid phase & combination of monoclonal antibodies & polyclonal antibodies in the conjugate to enable best coverage of all the subtypes• reagents should be preferably colour coded • preferably colour change on addition of samples/reagents in the wells.• total incubation time should not be more than 2 hrs• sample volume should be small preferably not be more than 100ul• the assay should have reactive and non reactive controls with each kit. • sensitivity should be more than 99.9%• analytical sensitivity should be less than 60 picogram/ml.• specificity should be more than of 99.5%• adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the assay should have a shelf life on minimum 9 months at the time of delivery.• the manufacturer/authorized agent should ensure maintenance of cold chain during storage and transport at 20c 80c. • the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• the kit size should be 96 wells per kit. 78 hiv elisa test kits • should be fourth generation elisa kit.• should detect both antibody (ab) of hiv 1 group m (all known hiv 1 subtypes a, b, c, d, e, f, g and h), hiv 1 group o and hiv 2 as well as p24 antigen (ag) against hiv 1 .• should be solid phase micro plate based on sandwich elisa with monoclonal abs against p24 ag and gp160 recombinant proteins on the solid phase.• should have gp36 and gp 41 peptides in the conjugate. • should have separate conjugates for both antigens and antibodies • reagents should preferably be colour coded with verification criteria for reagent addition proof.• should detect all the three classes of antibodies to hiv i.e. igm, igg and iga simultaneously providing highest early sero conversion sensitivity.• total incubation time should not be more than 2 hrs.• sample volume should be small preferably not be more than 100ul• the assay should have positive (anti hiv1, anti hiv2 and hiv p24 antigen) controls with each kit. • the assay should have negative (non reactive) control with each kit. • the assay should have sensitivity of more than 99.9%.• the analytical sensitivity of ag detection should be less than 150 pg/ml .• specificity should be more than of 99.5% for both antigens as well as antibodies without compromising the assay sensitivity.• adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the assay should have a shelf life of minimum 9 months at the time of delivery.• the manufacturer/authorized agent should ensure maintenance of cold chain during storage and transport at 20c 80c. • the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• the kit size should be 96 wells per kit 79 hiv elisa for anti hiv 1 and 2 antibodies • 96 well elisa 3 rd generation •should detect both antibody (ab) of hiv 1 group m (all known hiv 1 subtypes a, b, c, d, e, f, g and h), hiv 1 group o and hiv 2. • should be solid phase micro plate based on sandwich elisa with monoclonal abs against p24 ag and gp160 recombinant proteins on the solid phase.• should have gp36 and gp 41 peptides in the conjugate. • should have separate conjugates for both antigens and antibodies • reagents should preferably be colour coded with verification criteria for reagent addition proof.• should detect all the three classes of antibodies to hiv i.e. igm, igg and iga simultaneously providing highest early sero conversion sensitivity.• total incubation time should not be more than 2 hrs.• sample volume should be small preferably not be more than 100ul• the assay should have positive (anti hiv1, anti hiv2 and hiv p24 antigen) controls with each kit. • the assay should have negative (non reactive) control with each kit. • the assay should have sensitivity of more than 99.9%.• the analytical sensitivity of ag detection should be less than 150 pg/ml .• specificity should be more than of 99.5% for both antigens as well as antibodies without compromising the assay sensitivity.• adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the assay should have a shelf life of minimum 9 months at the time of delivery.• the manufacturer/authorized agent should ensure maintenance of cold chain during storage and transport at 20c 80c. • the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• the kit size should be 96 wells per kit • elisa reader based test• must detect both hiv 1 and 2 antibody.• negative predictive value 0.01 %• kit must be as per naco guidelines. 80 hcv elisa test kits fourth generation hcv elisa kit• should detect igg antibody against hcv. • should have wells coated with recombinant antigens: c22c, c 200(c 33c + c 100), ns3, ns4, ns5.• should have murine monoclonal anti igg with hr peroxidase enzyme conjugate and it should be ready to use. • the sero conversion sensitivity should be based on minimum 20 anti hcv sero conversion panel study, and it should have highest earlysero conversion sensitivity.• total incubation time should not be more than 2 hrs• sample volume should be small preferably not be more than 100ul• the assay should have reactive and non reactive controls with each kit.• sensitivity of the test should be more than 99.9%• specificity should be more than of 99.5% for ab detection without compromising the assay sensitivity.• adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the assay should have a shelf life on minimum 9 months at the time of delivery.• the manufacturer/authorized agent should ensure maintenance of cold chain during storage and transport at 20 c 80c. • the kit procured should have approval of the statutory authority in it country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• the kit size should be 96 wells per kit• the kit should be coated with immunodominant regions of the virus:core, ns3, ns4, and ns5. 81 hcv elisa test • 96 well elisa 3rd generation • serum can be used as sample.• both sensitivity & specificity should be more than 99 %.• documented study should be provided along with tender for sensitivity & specificity claims. • should have shelf life of 1 – 2 years. • should be stored at room temperature or in refrigerator (2 – 8 c).• company should provide good manufacturing product (gmp)/ who certificate & iso 13485 certificate / fda approved along with tender. • kit should provide all accessories & positive and negative controls.• for elisa kit, 12 strips of 8 wells should be supplied• should have good consumer base in gujarat.• expiry should be 1 – 2 year from date of manufacturing.• it is preferable, if kit is approved by any apex govt. institute in india.• it is preferable, if kit has good rapport in commercial market since last 3 years.• detailed literature regarding kit should be provided along with tender.• the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• authority letter from manufacturer is mandatory.• for imported item, ce certificate is must. 82 hiv, hcv, hbsag combo elisa test kit • should be fourth generation elisa kit based on sandwich principle of enzyme linked immunosorbent assay (elisa).• should detect both antibody (ab) of hiv 1 group m (all known hiv 1 subtypes a, b, c, d, e, f, g and h), hiv 1 group o and hiv 2 as well as p24 antigen (ag) against hiv 1 ; should detect igg antibody against hcv and wells coated with recombinant antigens: c22c, c 200 (c 33c + c 100), ns3, ns4, ns5 ; should detection hepatitis b surface antigen (hbsag) in human serum or plasma and detect all known subtypes like ayw1, ayw2, ayw3, ayw4, ayw5, ayr, adw2, adw4, adr and mutant strains. •the assay should have sensitivity of more than 99.9% and specificity of 99.5%. •total incubation time should not be more than 2 hrs. • sample volume should be small preferably not be more than 100ul • the assay should have positive and negative controls with each kit. •adequate literature detailing the components, methodology, validity, criteria, performance characteristics, storage conditions and expiry date should be provided with each kit • the assay should have a shelf life on minimum 9 months at the time of deliver • the manufacturer/authorized agent should ensure maintenance of cold chain during storage and transport at 20c 80c. • the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• the kit size should be 96 wells per kit. •the kits should be supplied with compatible fully automatic elisa machine. the machine should have random access 4 plate elisa processor with non conductive cross contamination free disposable tips • 2 needle multi purpose lhs (liquid handling system) • process security through alarm system • up to 12 assays at a time • powerful operating software with integrated quality control • password protected user’s operation• lis – bidirectional interface to exchange information • positive identification of samples, microplates and reagents with monitoring of sample, and reagent pipetting including low volume, clot detection • 4 plates of 96 wells • 4 independent incubators. • 180 sample positions. • 24 reagent positions. • 36 control/standard position • 2 pre dilution positions • 4 × 108 tips positions. 83 hiv rapid test •the kit should be 4th generation immunochromatography, based on sandwich principle for qualitative detection of hiv antibodies.• the kit should be designed to detect: human specific igg and igm antibodies hiv 1 group m & group o;all known hiv1 subtypes a, b, c, d, e, f, g and h hiv 2• the kit should be able to detect antibodies to hiv 1 & 2 during early sero conversion period. evidence based sero conversion data should be provided. • samples can be used: serum, plasma (heparinated, edta),venous whole blood, capillary blood• the kit should have stability for 18 months at +4 to +30°c. • the kit should have positive and negative controls• the kit should be designed for near patient testing: minimum training required no centrifugation (if capillary or whole blood) time to result: 15 min (maximum 30 minutes for negative result).• sensitivity: serum & plasma: 99.5%.;whole blood: 99.9%.• specificity: serum & plasma: 99.5%.; whole blood: 99.5%.• preferably should be ce certified for hiv 1/2.• easy to use (no material required).• adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• maintenance of cold chain during storage and transport at 20c – 80c.• the kit should have a shelf life of minimal 12 months at the time of delivery.• preferable pack size shall not be more than 50 tests wherein each device should be individually packed 84 hbsag rapid test kits • rapid, visual, qualitative test based on the association of monoclonaland polyclonal antibodies specific to hepatitis b virus.• a rapid test using immuno chromatography technology (ict or lateral flow) for the qualitative detection of hbsag.• the kit should detects all known hbsag subtypes and mutation monoclonal antibodies :adw2, adw4, adrq+, ayw1, ayw2, ayw3, ayw4, and ayr.• samples that can be used: serum plasma (heparinated, edta) venous whole blood capillary blood• the kit should have a stability of 18 months at 4 to 30°c.• the kit should be designed for near patient testing:• minimum training required• no centrifugation (if capillary or whole blood)• time to result: 15 minutes (maximum 30 minutes for negative result)• sensitivity: serum & plasma: 99.9%.;whole blood: 99.9%.• specificity: serum & plasma: 99.5%.;whole blood: 99.5%.• easy to use (no material required).• adequate literature detailing the components, methodology, validitycriteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have beeregistered and licensed in india by dcg (i)• maintenance of cold chain during storage and transport at 20c – 80c.• the kit should have a shelf life of minimal 12 months at the time of delivery.• preferable pack size shall not be more than 50 tests wherein eachdevice should be individually packed. 85 hcv rapid test kits 4th generation kit based on immunofiltration / chromatography•should be rapid, visual, sensitive and qualitative in vitro diagnostic kit for the detection of antibodies of hepatitis c virus in human serum and plasma.•should detect antibodies to putative core, ns3, ns4, and ns5 regions of hcv.•samples can be used:o serumo plasma (heparinated, edta)•the kit should have stability for 18 months at +4 to +30°c. • the kit should have positive and negative controls• the kit should be designed for near patient testing:•minimum training required•no centrifugation (if capillary or whole blood)• time to result: 15 min (maximum 30 minutes for negative result).• sensitivity: 100 %• specificity: 99.8%.• easy to use (no material required).• adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• maintenance of cold chain during storage and transport at 20c – 80c.• the kit should have a shelf life of minimal 12 months at the time of delivery.• preferable pack size shall be not more than 50 tests wherein each device should be individually packed 86 rapid malaria antigen detection rapid visual antigen based test for detecting infection with plasmodium falciparum (hrp 2) and plasmodium vivax (pldh) of malaria parasite in human whole blood.• easy to run. total run time should not be more than 30 minutes• easy to interpret colour bands.• storage at +40c to +300c• sensitivity of the test should be 100%• specificity of the test should be 99.8%• adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guidelines• the kit should have a shelf life of minimal 18 24 months at the time of delivery.• preferable pack size of 25 tests wherein each device should be individually packed 87 malaria elisa kit •malaria antigen elisa kit should have a principle of sandwich enzyme linked immunosorbent assay for the qualitative detection of the presence of plasmodium lactate dehydrogenase (pldh), an enzyme produced both in the sexual and asexual forms of parasite. and should have an excellent high level of sensitivity and specificity adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. •should be simple buffer assay rack for safety use•system configuration should be compatible with all common elisa equipments•stability : 12 months at 2~8? 88 tpha kits for syphilis detection • should be based on detection of antibodies to treponema pallidum in human serum or plasma.• should be based on the principle of haemagglutination using avian red cells.• should have positive and negative controls• the sensitivity should be > 99.8%• the specificity should be > 99.00%• the kit should have all accessories required for the test. adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit. • the kit should have a shelf life of minimal 18 24 months at the time of delivery.• preferable pack size of > 100 tests. • storage temperature for the kit should be +2 to +8oc 89 rpr for syphilis detection • should be bases on flocculation principle using non treponemal antigens.• qualitative determination of reagin antibodies in serum or plasma for sero diagnosis of syphilis.• should be calibrated to who reference serum. • should be suitable to use with either serum or plasma. • sensitivity should be > 70%• should be rapid preferably < 15 min• should have positive and negative controls• the kit should have all accessories required for the test such as cards, dropper, applicator.• the kit should have a shelf life of minimal 18 24 months at the time of delivery.• preferable pack size of > 100 tests. • storage temperature for the kit should be +2 to +8oc 90 syphilis elisa test kit • the kit should be based on “ sandwich†principle of enzyme linked immunosorbent assay(elisa) for the detection of igm and igg antibody against t. pallidum in human serum or plasma.• reagents should be preferably colour coded.• preferably colour change on addition of samples/reagents in the wells.• total incubation time should not be more than 2 hours.• sample volume should be small preferably not more than 100 µl.• the assay should have reactive and nonreactive controls with each kit.• sensitivity should be more than 99.9%.• specificity should be more than 99.5%.• adequate literature detailing the components, methodology, validity criteria, performance characteristics, storage conditions and expiry date should be provided with each kit.• the assay should have a shelf life of minimum 9 months at the time of delivery.• the manufacturer/authorized agent should ensure maintenance of cold chain during storage and transportation at 2 80 c.• the kit procured should have approval of the statutory authority in its country of origin. in case of imported kits it should have been registered and licensed in india by dcg (i) and as per naco guideline.• the kit size should be 96 wells per kit. 91 control sera for tti testing. • control sera (human base) for infectious diseases testing .• shelf life : minimum 2 year at 2–8oc• should have minimum 45 days open vial stability at 2–8oc• should be positive for anti hiv 1, anti hcv, hbsag, anti cmv.• should be compatible with all elisa kits and elisa machine. 92 single blood bag (350 ml) blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: single blood bag – 350 ml.should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpda label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 80c without breakage. 93 double blood bags(350ml) blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: • double bag primary bag 350 ml one satellite bag (300 ml)should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpda label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 80c without breakage. 94 double blood bag (450 ml) blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: • double bag primary bag 450 ml one satellite bag (300 ml)should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (63 ml) • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpda label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 80c without breakage. 95 double blood bags(350ml) blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: • double bag primary bag 350 ml one satellite bag (300 ml)should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml), 300ml transfer bag with 80ml additive solution & 100ml transfer bag pouch without transfusion port • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpda label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 80c without breakage. 96 double blood bag (450 ml) blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: • double bag primary bag 450 ml one satellite bag (300 ml)should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (63 ml), 300ml transfer bag with 80ml additive solution & 100ml transfer bag pouch without transfusion port • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpda label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 80c without breakage. 97 triple blood bag (350 ml) with sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity : triple blood bag primary bag – 350 ml first satellite bag (300 ml) containing additive solution for 42 days red cell storage. second satellite bag (300 ml) for platelet storage for 5 days• sample pouch/diversion pouch for collection of first 15 to 20 ml blood should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • additive solution (80 ml)• clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand 98 triple blood bag (350 ml) without sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: triple blood bag primary bag – 350 ml first satellite bag (300 ml) containing additive solution for 42 days red cell storage. second satellite bag (300 ml) for platelet storage for 5 days• sample pouch/diversion pouch for collection of first 15 to 20 ml blood should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • additive solution (80 ml)• additive solution (80 ml)• clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distor 99 triple blood bag (450 ml) with sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: triple blood bag primary bag – 450 ml first satellite bag (300 ml) containing additive solution for 42 days red cell storage. second satellite bag (300 ml) for platelet storage for 5 days• sample pouch/diversion pouch for collection of first 15 to 20 ml blood should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • additive solution (80 ml)• clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand 100 triple blood bag (450 ml) without sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: triple blood bag primary bag – 450 ml first satellite bag (300 ml) containing additive solution for 42 days red cell storage.second satellite bag (300 ml) for platelet storage for 5 days• sample pouch/diversion pouch for collection of first 15 to 20 ml blood should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • additive solution (80 ml) • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand 101 quadruple blood bag (350 ml) top and top with sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: quadruple blood bag primary bag – (350 ml) with top and top first satellite bag – containing additive solution for 42 days red cell storage second satellite bag (300 ml) for platelet storage for 5 daysthird satellite bag (300 ml) fourth satellite bag (100ml)• sample pouch/diversion pouch for collection of first 15 to 20 ml blood should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • additive solution (80 ml) – first satellite bag • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g 102 quadruple blood bag (350 ml) top and top without sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: quadruple blood bag primary bag – (350 ml) with top and top first satellite bag – containing additive solution for 42 days red cell storage second satellite bag (300 ml) for platelet storage for 5 days third satellite bag (300 ml)fourth satellite bag (100ml)• sample pouch/diversion pouch for collection of first 15 to 20 ml blood should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • additive solution (80 ml) • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperatu 103 quadruple blood bag (350 ml) top and bottom with sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: quadruple blood bag primary bag – (350 ml) with top and bottom first satellite bag – containing additive solution for 42 days red cell storage second satellite bag (300 ml) for platelet storage for 5 days third satellite bag (300 ml) • sample pouch/diversion pouch for collection of first 15 to 20 ml blood should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • additive solution (80 ml) • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity sh 104 quadruple blood bag (350 ml) top and bottom without sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: quadruple blood bag primary bag – (350 ml) with top and bottom first satellite bag – containing additive solution for 42 days red cell storage, second satellite bag (300 ml) for platelet storage for 5 days third satellite bag (300 ml) should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • cpda1 (49 ml) • additive solution (80 ml) primary bag only • additive solution (100 ml) – first satellite bag • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temper 105 quadruple blood bag (450 ml) top and top with sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: quadruple blood bag primary bag – (450 ml) with top and top. first satellite bag – containing additive solution for 42 days red cell storage, second satellite bag (300 ml) for platelet storage for 5 daysthird satellite bag (300 ml) fourth satellite bag (100ml) should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • • cpd ( 63 ml) – primary bag only • additive solution (100 ml) – first satellite bag • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temp 106 quadruple blood bag (450 ml) top and top without sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: quadruple blood bag primary bag – (450 ml) with top and bottom or top and top. first satellite bag – containing additive solution for 42 days red cell storage, second satellite bag (300 ml) for platelet storage for 5 days , third satellite bag (300 ml), fourth satellite bag (100ml) should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • • cpd ( 63 ml) – primary bag only • additive solution (100 ml) – first satellite bag • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capa 107 quadruple blood bag (450 ml) top and bottom with sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: quadruple blood bag : primary bag – (450 ml) with top and bottom . first satellite bag – containing additive solution for 42 days red cell storage second satellite bag (300 ml) for platelet storage for 5 daysthird satellite bag (300 ml) should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • • cpd ( 63 ml) – primary bag only • additive solution (100 ml) – first satellite bag • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g 108 quadruple blood bag (450 ml) top and bottom without sample pouch blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: quadruple blood bag : primary bag – (450 ml) with top and bottom . first satellite bag – containing additive solution for 42 days red cell storage , second satellite bag (300 ml) for platelet storage for 5 daysthird satellite bag (300 ml) should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • • cpd ( 63 ml) – primary bag only • additive solution (100 ml) – first satellite bag • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000 109 penta blood bag (450 ml) with sample pouch with in line leukocyte reduction filter blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination. capacity: penta blood bag primary bag – (450 ml) with top and bottom or top and top. first satellite bag – containing additive solution for 42 days red cell storagesecond satellite bag (300 ml) for platelet storage for 5 days third satellite bag (300 ml)fourth satellite bag (300 ml) should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • • cpd ( 63 ml) – primary bag only • additive solution (100 ml) – first satellite bag • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity 110 penta blood bag (450 ml) without sample pouch with in line leukocyte reduction filter blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: penta blood bag primary bag – (450 ml) with top and bottom or top and top. first satellite bag – containing additive solution for 42 days red cell storagesecond satellite bag (300 ml) for platelet storage for 5 days third satellite bag (300 ml)fourth satellite bag (300 ml) should comply to iso 3826 standards for all the parameters & confirms to iso3826 should be printed on label. • sterilization process should be according to iso 17665 1 • should reduce moisture loss design and shapes:• flexible pre sterilized, pyrogen free , non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags). • slit on the both sides of the bags. tubing of bag:• flexible non kinking, non sticking ,transparent • leak proof. • the tubing should have same id number as that on the bag • the tube should have multiple printed id numbers with clear visibility. needle:• 16 gauge ultra thin walled and straight. • sharp regular margins and beveled tip.• rust proof. • tightly fixed with hub covered with sterile guard. • hermetically sealed external port: • tamper proof • shouldn’t be re capped • easily accessiblepackage: • protective dual packaging (individual & 4 layer aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle anticoagulant and preservative solution: • • cpd ( 63 ml) – primary bag only • additive solution (100 ml) – first satellite bag • clear & colourless • no discolouration on storage at room temperature• manufacturer to supply anticoagulant quality check certificate along with stability test report on cpd sagm label:• non peel off • heat sealed labels • remain attached between room temperature to 80c with a transparent adhesive • date of manufacturing, date of expiry and lot number must be mentioned on each bag, should have barcode printing and not stamping • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand 111 quintiple inline filter bags • quintuple in line redcell filter 450ml bags with sagm 4 pvc dehp bags and 1 pvc totm coated bag and lcrd filter for plasma, buffy coat derived paltelte cocnentrate and leuco depleted red cell concentrate preparation • soft housing lcrd filter offers a first step to move buffy coat method with short filtrationduration below 20 min and optimal leucoreduction • high componenet recovery filter >90%. • lcrd enables the filteration up to 24 hrs after collection at room temperature and up to 48 hrs after collection and storage at 1 ?c to 6 ?c • angled bevel 16 guage needle with silicon coating to reduce penetration force , • color making at the top of the hub indicating the bevel orientation and needle diameter , • molded needle hub with lining • same segment no in each tubing, • bactivam – pre donoation sampling pouch allows collection of 40ml of blood that may contain skin bacteria thus prevents contamination of complete blood unit and safety of receipients • secuvam – needle safety guard with unique locking mechanism to cover needle after blood collection ensuring safety of healthcare workers from needle stick injuries. irreversible lock with audio locking system 112 quadruple inline filter bags • quadruple in line redcell filter 450ml bags with sagm 4 pvc dehp bags and a lcrd filter for plasma, buffy coat and leuco depleted red cell concentrate preparation • soft housing lcrd filter offers a first step to move buffy coat method with short filtrationduration below 20 min and optimal leucoreduction • high componenet recovery filter >90%. • lcrd enables the filteration up to 24 hrs after collection at room temperature and up to 48 hrs after collection and storage at 1 ?c to 6 ?c • angled bevel 16 guage needle with silicon coating to reduce penetration force , • color making at the top of the hub indicating the bevel orientation and needle diameter , • molded needle hub with lining • same segment no in each tubing, • bactivam – pre donoation sampling pouch allows collection of 40ml of blood that may contain skin bacteria thus prevents contamination of complete blood unit and safety of receipients • secuvam – needle safety guard with unique locking mechanism to cover needle after blood collection ensuring safety of healthcare workers from needle stick injuries. irreversible lock with audio locking system 113 buffy coat pooling set • buffy coat pooling system comes with manifold 6 tubings for buffy pooling , dedicated tubing for additive solution bag , txp filter (optimal solution for leucocyte removal from platelet concentrate ) ,2 pvc dehp bags and 1pvc bthc(oxy pl) bag for platelet storage • train and octopus both buffy pooling method can be done • centrifuge compatable bags and filter • paltelet storage bag made of pvc bthc allows a better platlet viability due to its permiability • extremely high leucreduction preformace with a log reduction higher than 4 • validated upto 24hrs after the collection v) platelet storage volume 1800 ml • scd compatable tubings vii) screw on/off sampling site viii) steam sterilizationn used and comes with 2 years shelf life 114 paediatric blood bag blood collection bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.should comply to iso 3826 standards for all the parameters, iso 3826 test reports should be submitted. capacity : 100 ml design and shapes: • flexible pre sterilized • pyrogen free • non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all eaks proof seals (disposable bags). • slit on the both sides of the bagstubing of bag: • flexible non kinking • non sticking • transparent • leak proof • the tubing should have same id number as that on the bag. • the tube should have multiple printed id numberspackage: • protective dual packaging (individual & aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle label:• non peel off • heat sealed labels • remain attached between room temperature to 800c with a transparent adhesive• date of manufacturing, date of expiry and lot number must be mentioned on each bag • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 800c without breakage. 115 transfer bags (100 ml) capacity transfer bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: single blood bag – 100 mlshould comply to iso 3826 standards for all the parameters, design and shapes:• flexible pre sterilized• pyrogen free • non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags).• slit on the both sides of the bags tubing of bag:• flexible non kinking• non sticking • transparent • leak proof • the tubing should have same id number as that on the bag • the tube should have multiple printed id numberspackage: • protective dual packaging (individual & aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle label:• non peel off • heat sealed labels • remain attached between room temperature to 800c with a transparent adhesive• date of manufacturing, date of expiry and lot number must be mentioned on each bag • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 4c to 24c without becoming permanently distorted and should withstand temperature upto 80c without breakage. 116 transfer bags (300 ml) capacity transfer bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: single blood bag – 300 mlshould comply to iso 3826 standards for all the parameters,design and shapes:• flexible pre sterilized• pyrogen free • non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags).• slit on the both sides of the bags tubing of bag:• flexible non kinking• non sticking • transparent • leak proof • the tubing should have same id number as that on the bag • the tube should have multiple printed id numberspackage: • protective dual packaging (individual & aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle label:• non peel off • heat sealed labels • remain attached between room temperature to 800c with a transparent adhesive• date of manufacturing, date of expiry and lot number must be mentioned on each bag • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 800c without breakage. 117 transfer bags (600 ml) capacity transfer bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: single blood bag – 600 mlshould comply to iso 3826 standards for all the parameters,design and shapes:• flexible pre sterilized• pyrogen free • non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags).• slit on the both sides of the bags tubing of bag:• flexible non kinking• non sticking • transparent • leak proof • the tubing should have same id number as that on the bag • the tube should have multiple printed id numberspackage: • protective dual packaging (individual & aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle label:• non peel off • heat sealed labels • remain attached between room temperature to 800c with a transparent adhesive• date of manufacturing, date of expiry and lot number must be mentioned on each bag • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 800c without breakage. 118 transfer bags (1000 ml) capacity transfer bag made up of dehp plasticized pvc, collapsible, collapsible non vented sterile containers complete with collecting tube for completely closed system to avoid the chances of contamination.capacity: single blood bag – 1000 mlshould comply to iso 3826 standards for all the parameters, design and shapes:• flexible pre sterilized• pyrogen free • non toxic, non haemolytic, biocompatible material • no risk of contamination and air embolism (closed system) with all leaks proof seals (disposable bags).• slit on the both sides of the bags tubing of bag:• flexible non kinking• non sticking • transparent • leak proof • the tubing should have same id number as that on the bag • the tube should have multiple printed id numberspackage: • protective dual packaging (individual & aluminum) eliminating microbial contamination on surface maintaining the contents of the bag.• easy to handle label: • non peel off • heat sealed labels • remain attached between room temperature to 800c with a transparent adhesive• date of manufacturing, date of expiry and lot number must be mentioned on each bag • the expiry date should be at least 2 years from the date of supply of blood bags to the instituteresistance to distortion: filled to normal capacity shall withstand a acceleration of 5000g for 30 min at temperature 40c to 240c without becoming permanently distorted and should withstand temperature upto 800c without breakage. 119 apheresis kit for sdp single needle (fresenius) • for model com.tec , fresenius kabi .• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure.• should able to perform procedure through single needle phlebotomy. 120 apheresis kit for sdp double needle (fresenius) • for model com.tec , fresenius kabi .• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure.• should able to perform procedure through double needle phlebotomy. 121 apheresis kits for tpe (fresenius) • for model com.tec , fresenius kabi .• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure. 122 apheresis kits for mnc collection (fresenius) • for model com.tec , fresenius kabi .• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure. 123 apheresis kits for leucocytapheresis. (fresenius) • for model com.tec , fresenius kabi .• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure. 124 apheresis kits for sdp single needle (fresenius) • for model amicus.• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure.• should able to perform procedure through single needle phlebotomy. 125 apheresis kits for sdp double needle (fresenius) • for model amicus.• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure.• should able to perform procedure through double needle phlebotomy. 126 apheresis kits for sdp (terumo bct) single needle • for model spectra optia , terumo bct .• disposable kit supplied with anticoagulant acd and normal saline withneedle set and other accessories required for procedure. 127 apheresis kits for sdp (terumo bct) double needle • for model spectra optia , terumo bct .• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure. 128 apheresis kits for plasmapheresis (terumo bct) • for model spectra optia , terumo bct .• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure. 129 apheresis kits for tpe and red cell exchange (terumo bct) • for model spectra optia , terumo bct .• disposable kit supplied with anticoagulant acd and normal saline withneedle set and other accessories required for procedure. 130 apheresis kits for mnc collection (terumo bct) • for model spectra optia , terumo bct .• disposable kit supplied with anticoagulant acd and normal saline with needle set and other accessories required for procedure. 131 red cell leukodepletion filters lab side •should provide 4 log reduction of leucocytes.•should be made of proven biocompatible material which is negatively charged.•if the filter requires priming, it should be suitable for easy and small volume priming. rinsing of the filter should not required. •for laboratory type filter there should be a convenient system for air vent facility.•rbc losses should not be greater than 10%.•sterilization by ethylene oxide gas• should avoid cellular inactivation 132 red cell leukodepletion filters lab side •should provide 4 log reduction of leucocytes.•should be made of proven biocompatible material which is positively charged.•if the filter requires priming, it should be suitable for easy and small volume priming. rinsing of the filter should not required. •for laboratory type filter there should be a convenient system to remove air from filtered blood with bypass line or air vent facility.•rbc losses should not be greater than 10%.•sterilization by ethylene oxide gas• should avoid cellular inactivation 133 red cell leukodepletion filters lab side with transfer bag •should provide 4 log reduction of leucocytes. with transfer bag with 600 ml capacity•should be made of proven biocompatible material which is neutral.•if the filter requires priming, it should be suitable for easy and small volume priming. rinsing of the filter should not required. •for laboratory type filter there should be a convenient system for air vent facility.•rbc losses should not be greater than 10%.•sterilization by ethylene oxide gas• should avoid cellular inactivation 134 red cell leukodepletion filters lab side with transfer bag •should provide 4 log reduction of leucocytes. with transfer bag with 600 ml capacity•should be made of proven biocompatible material which is negatively charged.•if the filter requires priming, it should be suitable for easy and small volume priming. rinsing of the filter should not required. •for laboratory type filter there should be a convenient system for air vent facility.•rbc losses should not be greater than 10%.•sterilization by ethylene oxide gas• should avoid cellular inactivation 135 red cell leukodepletion filters lab side with transfer bag •should provide 4 log reduction of leucocytes. with transfer bag with 600 ml capacity•should be made of proven biocompatible material which is positively charged.•if the filter requires priming, it should be suitable for easy and small volume priming. rinsing of the filter should not required. •for laboratory type filter there should be a convenient system to remove air from filtered blood with bypass line or air vent facility.•rbc losses should not be greater than 10%.•sterilization by ethylene oxide gas• should avoid cellular inactivation 136 red cell leukodepletion filters lab side i) should have dockable labside redcell filter comes with leucolab lcg2b filter, 1pvc dehp transfer bag and pre filter 200micro meter ii) lcg2b enables the red cell concetrate filteration up to 24 hrs after collection at room temperature and up to 72 hours after collection and storage at 4 ?c iii) two layered filter system for up to 90% recovery of red cell iv) by pass system to maintain the sterility and recovery iv) sterilized by beta radiation v) performance as per aabb and european guidlines vi) three years self life 137 platelet leukodepletion filters lab side •should provide 4 log reduction of leucocytes.•should be made of proven biocompatible material which is neutral.• if the filter requires priming, it should be suitable for easy and small volume priming. rinsing of the filter should not required.•for laboratory type filter there should be a convenient system for air vent facility.• platelet loss should be minimal.• sterilization by ethylene oxide gas• should avoid cellular inactivation 138 platelet leukodepletion filters lab side •should provide 4 log reduction of leucocytes.•should be made of proven biocompatible material which is negatively charged.• if the filter requires priming, it should be suitable for easy and small volume priming. rinsing of the filter should not required.•for laboratory type filter there should be a convenient system for air vent facility.• platelet loss should be minimal.• sterilization by ethylene oxide gas• should avoid cellular inactivation 139 platelet leukodepletion filters lab side •should provide 4 log reduction of leucocytes.•should be made of proven biocompatible material which is positively charged.• if the filter requires priming, it should be suitable for easy and small volume priming. rinsing of the filter should not required.•for laboratory type filter there should be a convenient system for air vent facility.• platelet loss should be minimal.• sterilization by ethylene oxide gas• should avoid cellular inactivation 140 platelet leukodepletion filters lab side i) should have labside platelet filters txp filter (optimal solution for leucocyte removal from platelet concentrate ) ,1 pvc dehp bag and 1pvc bthc(oxy pl) bag for platelet storage ii) paltelet storage bag made of pvc bthc allows a better platlet viability due to its permiability iii) extremely high leucreduction preformace with a log reduction higher than 4 iv) validated upto 24hrs after the collection v) platelet storage volume 1800 ml vi) scd compatable tubings vii) screw on/off sampling site viii) steam sterilizationn used and comes with 2 years shelf life 141 standard blood transfusion set • standard blood transfusion sets should be made up of medical grade pvc, designed for transfusion of blood or blood component. • the plastic should be non toxic and pyrogen free. • it should have a moulded cylindrical drip chamber fitted with sharp plastic spike and a nylon filter with a pore size ranging from 170 260 microns.• the drip chamber containing the filter should be clear, transparent and have an adequate space for drop rate counting. the filter should be on top drip chamber for easy management• the plastic of the drip chamber and blood transfusion set tubing should have good elastic recoil to withstand manual or roller clamp compression.• there should be a roller type regulator for accurate control of flow of blood or blood component • the male port should be sturdy at least 1½ inches long with vertical slits for proper flow of blood. • female port should be able to fit snuggly with all the available venous access devices in the market. • there should be moulded bubble latex tube attached to the female port for extra medication • 18 g vein needle with protective cap. • it should be pre sterilized with ethylene oxide /gamma rays and ready for use. • it should accompany a sterility report. • all pvc items should be of certified medical grade only. • all the connections in the blood transfusion set should be leak proof.• standards:iso 10993;is 1135;usp class iv;ce 142 copper sulphate powder ( cuso4, 5 h2o) 250gm per pack ar of glaxo/e.merk/ranbaxy/unilab 143 ammonium hydroxide 500gm per pack ar glaxo/e.merk/ranbaxy/unilab 144 sulphuric acid h2so4 0.5 mol/l 1n 1 liter pack ar glaxo/e.merk/ranbaxy/unilab 145 ammonium oxalate powder 250 gm per pack glaxo/e.merk/ranbaxy/unilab 146 acid hydrochloride 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 147 dextrose powder 1 kg per pack latex agglutination ar glaxo/e.merk/ranbaxy/unilab 148 field stain a 500ml per pack ar glaxo/e.merk/ranbaxy/unilab 149 field stain b 500ml per pack ar glaxo/e.merk/ranbaxy/unilab 150 edta salt 250 gm per pack ar/ex/lobal/bdh/glaxo 151 gentian violet 100 gm /pack ar glaxo/e.merk/ranbaxy/unilab 152 giemsa stain 100ml bottle ar glaxo/e.merk/ranbaxy/unilab 153 giemsa stain 500ml bottle ar glaxo/e.merk/ranbaxy/unilab 154 glyserin ip 500 ml per pack ar glaxo/e.merk/ranbaxy/unilab 155 koh powder 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 156 leishman stain 100gm per pack ar glaxo/e.merk/ranbaxy/unilab 157 leishman stain 250 mg per pack ar glaxo/e.merk/ranbaxy/unilab 158 methylene blue staining reagent for reticulocytes 125 ml per pack glaxo/e.merk/ranbaxy/unilab 159 potassium permanganet crystal 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 160 potassium dihydrogen orthophosphate 500gm per pack ar glaxo/e.merk/ranbaxy/unilab 161 potassium ferrocyanide 100gm per pack ar glaxo/e.merk/ranbaxy/unilab 162 potassium ferrocyanide 250gm per pack ar glaxo/e.merk/ranbaxy/unilab 163 reticulin stain 100 gm per pack ar glaxo/e.merk/ranbaxy/unilab 164 sodium citrate 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 165 sodium citrate 1 kg per pack ar glaxo/e.merk/ranbaxy/unilab 166 sodium hydroxide 100gm per pack ar glaxo/e.merk/ranbaxy/unilab 167 sodium hydroxide 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 168 sodium carbonate 500gm per pack ar glaxo/e.merk/ranbaxy/unilab 169 sodium thiosulphate 500gm. per pack ar glaxo/e.merk/ranbaxy/unilab 170 sodium acetate 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 171 sodium dihydrogen orthophosphate 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 172 sodium ferricyanide 100gm per pack ar glaxo/e.merk/ranbaxy/unilab 173 sodium ferricyanide 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 174 sodium metabisulphate 100gm. per pack ar glaxo/e.merk/ranbaxy/unilab 175 phosphoric acid 250 ml per pack ar glaxo/e.merk/ranbaxy/unilab 176 phosphoric acid 1 ltr per pack ar glaxo/e.merk/ranbaxy/unilab 177 wright stain 1 ltr per pack ar glaxo/e.merk/ranbaxy/unilab 178 trisodium citrate ar 500gm per pack ar glaxo/e.merk/ranbaxy/unilab 179 papain powder 50 gm/pack ar glaxo/e.merk/ranbaxy/unilab 180 dtt(dithiothreitol) powder 50 gm/pack ar glaxo/e.merk/ranbaxy/unilab 181 l cysteine hydeochloride powder 5 gm/pack ar glaxo/e.merk/ranbaxy/unilab 182 imidazole powder 50 gm/pack ar glaxo/e.merk/ranbaxy/unilab 183 2 me(2 mercaptoetanol ) powder 50 gm/pack ar glaxo/e.merk/ranbaxy/unilab 184 phosphate buffer 50 gm/pack ar glaxo/e.merk/ranbaxy/unilab 185 dimethyl sulfoxide (dmso) 500 ml per pack ar glaxo/e.merk/ranbaxy/unilab 186 dimethyl sulfoxide (dmso) 20 ml per pack ar glaxo/e.merk/ranbaxy/unilab 187 polyethylene glycol 500 ml per pack ar glaxo/e.merk/ranbaxy/unilab 188 ficin powder 50 gm/pack ar glaxo/e.merk/ranbaxy/unilab 189 bovine thrombin powder 1 gm per pack 50 nih u/mg ar glaxo/e.merk/ranbaxy/unilab 190 glycerol powder 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 191 potassium hydrogen phosphate 500 gm per pack ar glaxo/e.merk/ranbaxy/unilab 192 double distilled water clear appearance. ph should be between 6 to 7. pack size 10 liter. 193 sodium hypochlorite solution 5% sodium hypochlorite solution.pack size : 5 lit. 194 thromboplastin reagent • reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•liquid stable rabbit brain thromboplastin reagent with a shelf life of at least 18 months at 2 8°c. •the reagent must be stable for 7 days at rt and 2 days at 37°c. •the reagent must be available in the market for at least 10 years. •pack 5 ml/12 x 5ml •shelf life: 12 months at 2 8°c •pack 6 x 1m 195 cephaloplastin reagent reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•liquid stable rabbit brain cephaloplastin using ellagic acid as an activator with a shelf life of 18 months at 2 8°c. •the reagent must be stable for 7 days at rt and 2 days at 37°c. •shelf life: 12 months at 2 8°c •pack 6 x 1ml. 196 actin fsl • reagent should compatible with semiautomatic coagulometer sysmex model ca 50.• liquid purified soy and rabbit phosphatides in ellagic acid with added buffer, stabilizers and preservative.• can be used manually and on fully automated coagulation machine.• the reagent must be stable for 7 days at 2 to 80 c once opened.• shelf life: 12 months at 2 8°c 197 fibrinogen reagent • reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•for quantitative estimation of fibrinogen. •the kit must include calibrator. •the reconstituted stability of thrombin reagent must be at least 2 weeks at 2 8°c. available in maximum 20 t packs. •shelf life: 12 months at 2 8°c 198 calcium chloride •reagent should compatible with semiautomatic coagulometer. sysmex model ca 50 and fully automated coagulation machine.•use for different coagulation assay.•cacl2 solution 0.025 mol/l.•pack size 10 x 15 ml.•shelf life: 12 months at 2 8°c. 199 owren’s kollar buffer • reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•use for different coagulation assay.•ph should be 7.4•shelf life: 12 months at 2 8°c. 200 owren’s veronal buffer • reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•use for different coagulation assay.•ph should be 7.4 • shelf life: 12 months at 2 8°c 201 imidazole buffer • reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•use for different coagulation assay.•ph should be 7.4 • shelf life: 12 months at 2 8°c 202 coagulometer quality control reagents • reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine. (lyocheck level 1, 2 and 3), should provide normal reference ranges for pt, aptt and fibrinogen 203 factor vii deficient plasma •reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•lyophilized human source plasma deficient in factor vii while having the other factors within normal limits. •the shelf life of the reagent must be at least 2 years. •the reconstituted stability of the reagent must be 1 month at 20°c. pack 5 x 1 ml •shelf life: 12 months at 2 8°c •pack 6 x 1ml. 204 factor viii deficient plasma •reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•lyophilized human source plasma deficient in factor viii while having the other factors within normal limits. •the shelf life of the reagent must be at least 2 years. •the reconstituted stability of the reagent must be 1 month at 20°c. •pack 5 x 1 ml •shelf life: 12 months at 2 8°c •pack 6 x 1ml. 205 factor ix deficient plasma • reagent should compatible with semiautomatic coagulometer sysmex model ca 50 and fully automated coagulation machine.•lyophilized human source plasma deficient in factor ix while having the other factors within normal limits. •the shelf life of the reagent must be at least 2 years. •the reconstituted stability of the reagent must be 1 month at 20°c. •pack 5 x 1 ml •shelf life: 12 months at 2 8°c •pack 6 x 1ml. 206 plasmatrol r •lyophilized preparation of human pool plasma with assayed values for pt/aptt/fibrinogen/factors ii, v, vii, viii, ix, x, xi and xii/protein c/protein s/antithrombin iii. •shelf life: 12 months at 2 8°c •pack 6 x 1ml. 207 cuvettes for ca 50 coagulometer cuvettes for semi auto coagulometer sysmex model ca 50 for coagulation test 208 pt reagent for il acl elite pro reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized preparation of rabbit thromboplastin and liquid preparation of buffer. •shelf life: 12 months at 2 8°c and 5 days after reconstitution of reagent at 40 c •pack : 5 x 8.5 ml reagent and 5 x 8.5 ml buffer 209 aptt reagent for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•aptt reagent with calcium chloride in lyophilized or liquid form.•shelf life: 12 months at 2 8°c and 30 days after opening of vial at 40 c•pack : 5 x 10 ml reagent and 5 x 10 ml buffer. 210 fibrinogen reagent for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized preparation of bovine thrombin. •shelf life: 12 months at 2 8°c.•pack : 10 x 2 ml reagent . 211 d dimer reagent for il acl elite pro •reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized preparation of latex reagent and d dimer calibrator and liquid preparation of reaction buffer.•shelf life: 12 months at 2 8°c and 30 days after reconstitution of reagent at 40 cpack : 4 x 3 ml reagent , 3 x 9 ml reaction buffer , 2 x 1 ml calibrator. 212 factor viii deficient plasma for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized human source plasma deficient in factor viii while having the other factors within normal limits. •the reconstituted stability of the reagent must be 1 month at 20°c. •pack 10 x 1 ml •shelf life: 12 months at 2 8°c 213 factor vii deficient plasma for il acl elite pro • reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized human source plasma deficient in factor viii while having the other factors within normal limits. •the reconstituted stability of the reagent must be 1 month at 20°c. •shelf life: 12 months at 2 8°c •pack 10 x 1ml. 214 factor ix deficient plasma for il acl elite pro • reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized human source plasma deficient in factor ix while having the other factors within normal limits. •the reconstituted stability of the reagent must be 1 month at 20°c. •shelf life: 12 months at 2 8°c •pack 10 x 1ml. 215 factor ii deficient plasma for il acl elite pro • reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized human source plasma deficient in factor ii while having the other factors within normal limits. •the reconstituted stability of the reagent must be 1 month at 20°c. •shelf life: 12 months at 2 8°c •pack 10 x 1ml. 216 factor v deficient plasma for il acl elite pro • reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized human source plasma deficient in factor v while having the other factors within normal limits. •the reconstituted stability of the reagent must be 1 month at 20°c. •shelf life: 12 months at 2 8°c •pack 10 x 1ml. 217 factor x deficient plasma il acl elite pro • reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized human source plasma deficient in factor x while having the other factors within normal limits. •the reconstituted stability of the reagent must be 1 month at 20°c. •shelf life: 12 months at 2 8°c •pack 10 x 1ml. 218 factor xi deficient plasma for il acl elite pro • reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized human source plasma deficient in factor xi while having the other factors within normal limits. •the reconstituted stability of the reagent must be 1 month at 20°c. •shelf life: 12 months at 2 8°c •pack 10 x 1ml. 219 factor xii deficient plasma for il acl elite pro • reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•lyophilized human source plasma deficient in factor xii while having the other factors within normal limits. •the reconstituted stability of the reagent must be 1 month at 20°c. •shelf life: 12 months at 2 8°c •pack 10 x 1ml. 220 vwf antigen reagent for il acl elite pro •reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.• liquid latex reagent and liquid preparation of reaction buffer.•shelf life: 12 months at 2 8°c and 7 days after reconstitution of reagent at 40 cpack : reagent 2 x2 ml and substrate 4 x 4 ml 221 reagnet for vwf recof us fda approved test kits should be compitibale with il instruments; 2x2ml 222 vwf activity reagent for il acl elite pro •reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.• liquid latex reagent and liquid preparation of reaction buffer.•shelf life: 12 months at 2 8°c and 7 days after reconstitution of reagent at 40 cpack : reagent 2 x4.5 ml and buffer 2 x 4.5 ml 223 aptt reagent for la test for il acl elite pro reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.• reagent should be used for lupus anticoagulant assay.•shelf life: 12 months at 2 8°c and 7 days after reconstitution of reagent at 40 cpack : aptt reagent 5 x9 ml and calcium chloride 5 x 8 ml 224 reagent for drvvt screen and la screen for il acl elite pro reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.• reagent should be used for lupus anticoagulant assay. •shelf life: 12 months at 2 8°c and 15 days after reconstitution of reagent at 40 c pack : drvtt screen 10 x2 ml and drvvt confirm 10 x 2 ml 225 reagent for drvvt confirm and la confirm for il acl elite pro reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.• reagent should be used for lupus anticoagulant assay. •shelf life: 12 months at 2 8°c and 15 days after reconstitution of reagent at 40 c pack : drvtt scrren 10 x2 ml and drvvt confirm 10 x 2 ml 226 la positive control for il acl elite pro reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. pack : 1x10 ml 227 la negative control for il acl elite pro reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. pack : 1x10 ml 228 antithrombin reagent for il acl elite pro •reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.• liquid fxa reagent and liquid substrate.•shelf life: 12 months at 2 8°c and 5 weeks after reconstitution of reagent at 40 cpack : reagent 2 x3ml and buffer 2 x 4 ml 229 protein c reagent for il acl elite pro •reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.• lyophilized protein c activator and substrate and iquid diluents and working diluent.•shelf life: 12 months at 2 8°c and 90 days after reconstitution of reagent at 40 c pack : reagent 2 x2.5 ml and buffer 2 x 2.5 ml; diluent 1 x 8 ml. 230 free protein s reagent for il acl elite pro •reagents should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.• lyophilized recombinant tissue factor, ps deficient plasma and ps control plasma.•shelf life: 12 months at 2 8°c and 90 days after reconstitution of reagent at 40 cpack : reagent 3 x 3 ml; ps def plasma 5 x 1 ml; ps control plasma 2 x 1 ml. 231 rinse solution for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 232 reference emulsion solution for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 233 clean a for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 234 clean b for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 235 factor diluent for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 236 calibration plasma for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 237 normal control assayed for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 238 low abnormal control assayed for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 239 high abnormal control assayed for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.the shelf life of the reagent must be at least 1 year. 240 d dimer controls level 1 for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 241 d dimer controls level 2 for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 242 low fibrinogen control for il acl elite pro •reagent should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•the shelf life of the reagent must be at least 1 year. 243 rotors for il acl elite pro •should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•to perform different coagulation test. 244 cup for il acl elite pro •should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•to perform different coagulation test.•capacity : 0.5 ml 245 cup for il acl elite pro •should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•to perform different coagulation test.•capacity : 2 ml 246 clening solution clean a for il instrument; 1 x 500 ml 247 cleaning solution clean b for il instrument; 1 x 80 ml 248 cuvette for test cuvettes/ rotor for il instrument; 2400 test 249 cup for il acl elite pro •should compatible with fully automatic coagulometer of instrument and laboratory model acl elite pro.•to perform different coagulation test.•capacity : 4 ml 250 cell pack (diluent) for cell counter •for cell counter model sysmex kx 21•the shelf life of the reagent must be at least 1 year. 251 lyser (diluent) for cell counter •for cell counter model sysmex kx 21•the shelf life of the reagent must be at least 1 year. 252 cell clean for cell counter •for cell counter model sysmex kx 21•the shelf life of the reagent must be at least 1 year. 253 controls for cell counter •for cell counter model sysmex kx 21•the shelf life of the reagent must be at least 1 year. 254 calibrators for cell counter •for cell counter model sysmex kx 21•the shelf life of the reagent must be at least 1 year. 255 thermal paper for cell counter for cell counter model sysmex kx 21and to print cbc report from cell counter 256 cryovial to preserve the serum sample . 2ml vial 257 temperature recording chart for 2 60 c blood bag refrigerator helmer • for model hhb 120.• should be made up of good quality thermal paper and ink should not be spread out. • 7 days (weekly) temperature recording .• temperature range should be 500 to +20 0 c 258 temperature recording chart for 2 60c blood bag refrigerator haier • for model hxc 608 a.• 7 days (weekly) temperature recording .• should be made up of good quality thermal paper and ink should not be spread out. • temperature range should be 400 to +30 0 c 259 temperature recording chart for 2 60c blood bag refrigerator remi • for the model br300. • 7 days (weekly) temperature recording . • should be made up of good quality paper and ink should not be spread out. • temperature range should be 100 to +20 0 c 260 temperature recording chart for platelet incubator terumo penpol • for model pi200• 7 days (weekly) temperature recording .• should be made up of good quality paper and ink should not be spread out. • temperature range should be 0 to +40 0 c 261 temperature recording chart for 2 60 c refrigerator terumo penpol • for model bbr g600• 7 days (weekly) temperature recording .• should be made up of good quality paper and ink should not be spread out. • temperature range should be 0 to +40 0 c 262 temperature recording chart for 400 c refrigerator terumo penpol • for model df 40u• 7 days (weekly) temperature recording .• should be made up of good quality paper and ink should not be spread out. • temperature range should be 500 to +30 0c 263 temperature recording chart for 800 c refrigerator terumo penpol • for model df 80u • 7 days (weekly) temperature recording .• should be made up of good quality thermal paper and ink should not be spread out.• temperature range should be 1000 to +50 0 c 264 ink pen for temperature recording chart ink pen for temperature recording chart to record 7 days (weekly) temperature on chart . should be made up of good quality and ink should not be spread out. 265 thermel pen for temperature recording chart thermal pen for temperature recording chart to record 7 days (weekly) temperature on thermal chart . should be made up of good quality. 266 tips 2 200ul for dispensing samples/reagents in routine immunohematology tests 267 tips 100 1000 ul for dispensing samples/reagents in routine immunohematology tests 268 carbon biotips 300ul, for dispensing reagents in fully automatic elisa machine evolis 269 carbon biotips 1100ul, for dispensing reagents in fully automatic elisa machine evolis 270 disposable plastic test tubes • should made from good quality transparent colourless plastic.• size : 12 mm x 75 mm• without screw cap 271 disposable glass test tubes • should made from good quality transparent colourless glass.• size : 12 mm x 75 mm• without screw cap 272 glass slide • microscopic polished edge and lint free glass slides.• should made from transparent colourless glass.• should have refractive index (ne) 1.53 + 0.02.• size : 76 mm x 26 mm; thickness : 1.10 mm. 273 ph indicator strips range : 2 to 10.5. box of 10 strips graduation 1 ph, iso, sigma/ glaxo/siemens/beyer 274 ph indicator strips range : 5 to 8, graduation 0.5 ph box of 10 strips iso, sigma/ glaxo/siemens/beyer 275 ph indicator strips ph range 6.0 7.7 graduation 0.3 0.4 ph, iso, sigma/ glaxo/siemens/beyer 276 ph tablets use for measurement and calibration of ph meter with ph 4. 277 ph tablets use for measurement and calibration of ph meter with ph 7 278 ph tablets use for measurement and calibration of ph meter with ph 9.2 279 wafer wafer for tscd model sc 201(sterile tube connecting device) use for connecting tubings in sterile condition. 280 lancets for hb estimation and blood grouping by finger prick.should fit the lancet gun device.should have protective cap. 281 filter paper whatman / whatman type superquality.size 57 cm x 46 cm. 282 biological indicator • use for quality control of autoclaving.• should contain spores of bacillus stereothermophillus.• spores per unit should be 1.0 x 105 to 5 x 106• survival time limit for a suitable resistance should be 4.5 to 14 min.• indicator change the colour after autoclaving at 1210 c temperature for 30 min.• should packaged in a suitable primary overwrap package that does not adversely affect the performance of the indicator. 283 temperature indicator • use to monitor cold chain maintenance during transportation of blood and blood components. • response to temperature at or more than 90 c. • should have irreversible colour change in a window and simple to read.• response time to temperature should be not more than 2 hours.• should not require any activation to start the monitoring. accuracy ± 10 c.• self adhesive and easy to apply on blood bags.• no known toxicity of active material.• time temperature indicator technology used should be qualified by a recognized regulatory body. 284 temperature indicator • use to monitor cold chain maintenance during transportation of blood and blood components.• response to temperature at or more than 250 c. • should have irreversible colour change in a window and simple to read.• response time to temperature should be not more than 2 hours.• should not require any activation to start the monitoring. accuracy ± 10 c.• self adhesive and easy to apply on blood bags.• no known toxicity of active material.• time temperature indicator technology used should be qualified by a recognized regulatory body. 285 haemoglobin estimation test system for blood donor screening • haemoglobin estimation test system for blood donor screening. • should be based on broad spectrum photometric measurement of hb.• system should be light weight and easy to transport.• should measure hb of capillary whole blood.• digital display of result in gm/dl within 10 seconds with high accuracy and precision.• should be provided with reagent free disposable cuvette .• disposable cuvettes should not influenced by temperature and humidity.• should have built in self check before every measurement.• disposable cuvette should have long expiry (at least 12 months).• the system should have minimum 24 hours battery back up after full charging.• the equipments for measuring thehaemoglobin six in number should be provided with test system without any additional cost. the maintenence, repair and calibration will be the responsibility of vendor. 286 microcuvette for hb estimation. microcuvette for hb estimation for hemocue machine model hb 301.disposable microcuvette should have long expiry (at least 12 months).pack : 4 x 50 287 control for hemocue hb301 control for hemocue hb301 : high, low and normal control to verify hemocue hb 301. 288 antiseptic solution for phlebotomy • should be used for surgical cleaning of the arm(venipuncture site) of blood donor before collection of blood.• should be bactericidal, fungicidal and virucidal.• should be non allergic and non irritating.• should be supplied with plastic container for easy handling.• expiry : at least 12 months 289 disposable reagent troughs/reservoir • should be use for reagent reservoir e.g. buffer, conjugate, substrate during elisa testing.• should be made up of polypropylene/pvc with cylindrical shape and v shape bottom.• capacity : 20 ml.• size : height : 7.5 cm; diameter : 2.5 cm. 290 disposable reagent troughs/reservoir • should be use for reagent reservoir e.g. buffer, conjugate, substrate during elisa testing.• should be made up of polypropylene/pvc with rectangle shape and flat bottom.• capacity : 20 ml.• size : 9 x 6 x 2 cm.. 291 platelet additive solution 250ml •should be used for apheresis platelet concentrate or buffy coat platelet concentrate or random donor platelet in up to 80% platelet additive solution and 20% plasma to reduce plasma volume of platelet component to decrease adverse events e.g. trali and abo mismatch.•platelet quality, function, storage stability, morphology and cell integrity must be well maintained during processing and storage of platelet concentrate after adding platelet additive solution.•platelet product can be stored up to 5 days at 20 to 240 c in platelet incubator with agitator.•should be compatible with all available technologies for preparation of platelet components. (e.g. automated devices for whole blood and apheresis derived platelet.)•the container of solution should be made up of non pcv material e.g. polyolefin.•container should have connections for sterile connection and luer lock for easy connection to apheresis kits.•should have shelf life of 24 months.•the product should have been registered and licensed in india by dcg(i).•should be available in volume of 250 ml. 292 platelet additive solution 300ml • should be used for apheresis platelet concentrate or buffy coat platelet concentrate or random donor platelet in up to 80% platelet additive solution and 20% plasma to reduce plasma volume of platelet component to decrease adverse events e.g. trali and abo mismatch.•platelet quality, function, storage stability, morphology and cell integrity must be well maintained during processing and storage of platelet concentrate after adding platelet additive solution.•platelet product can be stored up to 5 days at 20 to 240 c in platelet incubator with agitator.•should be compatible with all available technologies for preparation of platelet components. (e.g. automated devices for whole blood and apheresis derived platelet.)•the container of solution should be made up of non pcv material e.g. polyolefin.•container should have connections for sterile connection and luer lock for easy connection to apheresis kits.•should have shelf life of 24 months.•the product should have been registered and licensed in india by dcg(i).•should be available in volume of 300 ml. 293 platelet additive solution 500ml • should be used for apheresis platelet concentrate or buffy coat platelet concentrate or random donor platelet in up to 80% platelet additive solution and 20% plasma to reduce plasma volume of platelet component to decrease adverse events e.g. trali and abo mismatch with polyolefin bag and two connectors (manual and apheresis) •platelet quality, function, storage stability, morphology and cell integrity must be well maintained during processing and storage of platelet concentrate after adding platelet additive solution.•platelet product can be stored up to 5 days at 20 to 240 c in platelet incubator with agitator.•should be compatible with all available technologies for preparation of platelet components. (e.g. automated devices for whole blood and apheresis derived platelet.)•the container of solution should be made up of non pvc material e.g. polyolefin.•container should have connections for sterile connection and luer lock for easy connection to apheresis kits.•should have shelf life of 24 months.•the product should have been registered and licensed in india by dcg(i).•should be available in volume of 500 ml. 294 dockcounter dockcounter for compodock fresenius model s 2 (sterile tube connecting device) use for connecting tubings of blood bags in sterile condition. 295 variant ii for hplc (bio rad) should compatible with variant ii for high performance liquid chromatography (hplc) (bio rad) including all reagents and accessories elusion buufer 1 2, whole blood primer, calibrator diluent set, cartridge, aliqote, wash diluent 296 controls for variant ii for hplc (bio rad) should compatible with variant ii for high performance liquid chromatography hplc (bio rad). cat # 553 (4 x 0.5 ml) lyphocheck a2 control ...

Directorate Of Employment And Training - Gujarat

31458924 bids are invited for blood group kit , hydrocloric acid ( hcl ) , hayems solution , turks solution , sodium chloride , leishman stain , fields stain a , fields stain b , liquiplastin reagent , calcium chloride , aptt kit , thrombin kit , triglyceride kit , creatinine kit , urea kit , uric acid kit , total protein kit , bilirubin kit , glucose kit , cholestrol kit , calcium kit , sgpt kit , sgot , benedict reagent , crystal violet , grams iodine , saffranine , barford reagent , albert stain , lugols iodine , ziehl neelson stain , carbon fushin , sulfuric acid , widal test kit , hiv kit , hbsag kit , pregnancy kit , igg, iga kit , hcbg kit , vdrl kit , thomas pipette rbc , thomas pipette wbc , lancet , aluminium foil paper , cover slip , slide , capillary , testtube 4ml , testtube 6ml , testtube 10ml , testtube 15ml , testtube rack ( small& medium ) , pipette stand , rubber sucker , auto tip 10microliter , auto tip 100microliter , auto tip 1000microliter , urine sugar strip , parafine oil , droper , red anticoagulant tube , sodium citrate tube , filter paperauto extension if any seller submits price in last 15 minutes, the rawill be auto extended by 15 minutes. ( a maximum of10 times ) total quantity : 6005...

Directorate Of Employment And Training - Gujarat

30965539 bids are invited for blood group kit , hydrocloric acid ( hcl ) , hayems solution , turks solution , sodium chloride , leishman stain , fields stain a , fields stain b , liquiplastin reagent , calcium chloride , aptt kit , thrombin kit , triglyceride kit , creatinine kit , urea kit , uric acid kit , total protein kit , bilirubin kit , glucose kit , cholestrol kit , calcium kit , sgpt kit , sgot , benedict reagent , crystal violet , grams iodine , saffranine , barford reagent , albert stain , lugols iodine , ziehl neelson stain , carbon fushin , sulfuric acid , widal test kit , hiv kit , hbsag kit , pregnancykit , igg, iga kit , hcbg kit , vdrl kit , thomas pipette rbc , thomas pipette wbc , lancet , aluminium foil paper , cover slip , slide , capillary , testtube 4ml , testtube 6ml , testtube 10ml , testtube 15ml , testtube rack ( small&medium ) , pipette stand , rubber sucker , auto tip10microliter , auto tip 100microliter , auto tip1000microliter , urine sugar strip , parafine oil , droper , red anticoagulant tube , sodium citrate tube , filter paperboq title raw material for mlt trade total quantity : 6005...

Health And Family Welfare Department - Gujarat

19881684 procurement of tab. inj. and miss items for hospital 125 anti rabies vaccine ( tissue culture / embryo ) 1ml vial im / id use 126 anti rabies vaccine of tissue culture / cell culture for intrmuscular / intra dermal use ( vaccine approved by dcgi ) 0.5 ml 127 anticoagulant inj. each ml contains adenoso of heamocoagulas isolated from venom of botropos jararacm of botropos atroxcontaining 0.9% of sodium chloride ip & 5.0% of phenol ip ( as preservative. ) 1 ml 128 anti snake venom serum inj. ( liquid ) ( lyophillized ) 129 anti snake venom serum inj. ( powder ) ( lyophillized ) 130 artemether injection 80 mg 131 artesunate 60mg / ml inj. 2 ml 132 artether 60mg / 1ml inj. 1 ml 133 atracurium besylate 10 mg / ml inj 10 ml vial 134 atracurium besylate 10 mg / ml inj 2.5 ml amp 135 atracurium besylate 10 mg / ml inj 5 ml amp 136 atropine sulphate injection ( for im / iv use ) 1 ml 137 atropine sulphate injection 0.6mg / ml, 30ml vial 138 azithromycin inj. 250mg 139 b12 + folic acid + vit c inj. vitcofol inj 140 benzathine penicillin inj.1200000 i.u. 141 benzyl penicillin inj.500000 i.u. 142 betamethasone inj. 4 mg / ml 2ml 143 betamethasone inj. 4mg / ml 1 ml 144 bevacizumab injection 145 bleomycin inj. 250mg 146 bupivacaine 0.5% inj. 20ml vial 147 bupivacaine hcl 0.5% heavy for spinal inj. 4 ml 148 bupivacaine hcl inj. ( for infiltration anaesthesia ) 20 ml 149 bupivacaine hydrochloride in dextrose injection 5mg + 80mg per ml 150 bupivacaine hydrochloride injection ( heavy ) ( for spinal anaesthesia ) 151 buprenorphine ip 0.3mg / ml inj 1 ml amp 152 butorphenol 1mg / ml. inj. 2 ml 153 butorphenol 1mg / ml. inj. 5 ml 154 caffeine citrate ip 20 mg / ml , 1 ml vial 155 caffeine citrate ip 20 mg / ml , 2 ml vial => open...

Employees State Insurance Corporation - Gujarat

17931015 tender for laboratory investigation: laboratory medicine / clinical pathology 1 urine routine ph, specific gravity, sugar, protein and microscopy 2 urine micro albumin 3 stool routine 4 stool occult blood 5 post coital smear examination 6 semen analysis laboratory medicine / haematology 7 hemoglobin (hb) 8 total leucocyte count (tlc) 9 differential leucocyte count (dlc) 10 e.s.r. 11 total red cell count with mcv,mch,mchc,drw 12 complete haemogram/cbc, hb, rbc count and indices, tlc, dlc, platelet, esr, peripheral smear examination 13 platelet count 14 reticulocyte count 15 absolute eosinophil count 16 packed cell volume (pcv) 17 peripheral smear examination 18 smear for malaria parasite 19 bleeding time 20 osmotic fragility test 21 bone marrow smear examination 22 bone marrow smear examination with iron stain 23 bone marrow smear examination and cytochemistry 24 activated partial thromboplastin time (aptt) 25 rapid test for malaria(card test) 26 wbc cytochemistry for leukemia –complete panel 27 bleeding disorder panel pt, aptt, thrombin time fibrinogen, d dimer/ fdp 28 factor assays factor viii 29 factor assays factor ix 30 platelet function test 31 tests for hypercoagulable states protein c, protein antithrombin. 32 tests for lupus anticoagulant 33 tests for antiphospholipid antibody igg, igm (for cardiolipin b2 glycoprotein 1) 34 thalassemia studies (red cell indices and hb hplc) 35 tests for sickling / hb hplc) laboratory medicine / blood bank 36 blood group & rh type 37 cross match 38 coomb’s test direct 39 coomb’s test indirect 40 3 cell panel antibody screening for pregnant female 41 11 cells panel for antibody identification 42 hbs ag 43 hcv 44 hiv i and ii 45 vdrl 46 rh antibody titer 47 platelet concentrate 48 random donor platelet(rdp) 49 single donor platelet (sdp aphresis)...

Employees State Insurance Corporation - Gujarat

16059582 expression of interest (eoi) for laboratory investigation 1 urine routine ph, specific gravity, sugar, protein and microscopy 2 urine microalbumin 3 stool routine 4 stool occult blood 5 post coital smear examination 6 semen analysis 7 haemoglobin (hb) 8 total leucocytic count (tlc) 9 differential leucocytic count (dlc) 10 e.s.r. 11 total red cell count with mcv,mch,mchc,drw 12 complete haemogram/cbc, hb,rbc count and indices, tlc, dlc, platelet, esr, peripheral smear examination 13 platelet count 14 reticulocyte count 15 absolute eosinophil count 16 packed cell volume (pcv) 17 peripheral smear examination 18 smear for malaria parasite 19 bleeding time 20 osmotic fragility test 21 bone marrow smear examination 22 bone marrow smear examination with iron stain 23 bone marrow smear examination and cytochemistry 24 activated partial thromboplastintime (aptt) 25 rapid test for malaria(card test) 26 wbc cytochemistry for leukemia –complete panel 27 bleeding disorder panel pt, aptt, thrombin time fibrinogen, d dimer/ fdp 28 factor assays factor viii 29 factor assays factor ix 30 platelet function test 31 tests for hypercoagulable states protein c,protein antithrombin 32 tests for lupus anticoagulant 33 tests for antiphospholipid antibody igg, igm (for cardiolipin and b2 glycoprotein 1) 34 thalassemia studies (red cell indices and hb hplc) 35 tests for sickling / hb hplc) 38 coomb’s test direct 39 coomb’s test indirect 40 3 cell panel antibody screening for pregnant female 41 11 cells panel for antibody identification 42 hbs ag 43 hcv 44 hiv i and ii 45 vdrl 46 rh antibody titer 47 platelet concentrate 48 random donor platelet(rdp) 49 single donor platelet (sdp aphresis) 50 routine h & e 51 special stain 52 immunohistochemistry(ihc) 53 frozen section 54 paraffin section 55 pap smear 56 body fluid for malignant cells 57 fnac 58 leukemia panel /lymphoma panel 59 pnh panel cd55,cd59 60 karyotyping...

Employees State Insurance Corporation - Gujarat

11680257 expression of interest for laboratory investigation laboratory medicine / haematology 7 haemoglobin ( hb ) 8 total leucocytic count ( tlc ) 9 differential leucocytic count ( dlc ) 10 e.s.r. 11 total red cell count with mcv, mch, mchc, drw 12 complete haemogram / cbc, hb, rbc count and indices, tlc, dlc, platelet, esr, peripheral smear examination 13 platelet count 14 reticulocyte count 15 absolute eosinophil count 16 packed cell volume ( pcv ) 17 peripheral smear examination 18 smear for malaria parasite 19 bleeding time 20 osmotic fragility test 21 bone marrow smear examination 22 bone marrow smear examination with iron stain 23 bone marrow smear examination and cytochemistry 24 activated partial thromboplastintime ( aptt ) 25 rapid test for malaria ( card test ) 26 wbc cytochemistry for leukemia –complete panel 27 bleeding disorder panel pt, aptt, thrombin time fibrinogen, d dimer / fdp 28 factor assays factor viii 29 factor assays factor ix 30 platelet function test 31 tests for hypercoagulable states protein c, protein s, antithrombin 32 tests for lupus anticoagulant 33 tests for antiphospholipid antibody igg, igm ( for cardiolipin and b2 glycoprotein 1 ) 34 thalassemia studies ( red cell indices and hb hplc ) 35 tests for sickling / hb hplc )...

Health And Family Welfare Department - Gujarat

8965361 supply of laboratory items ( part 6 ) 52 single blood bags cpda 350ml:bio compatibility of the plastic container must be certified by the manufacturer and supported by test reports of the following cell culture cytotoxicity, haemolysis, systemic injection, sensitisation, intracutaneous injection.stability studies data to prove 3 years shelf life shouldbe produced.ce mark and iso 9002 quality system certification.conformity to iso 3826 international product std.for blood bags.in_house r&d center recognised by the govt. of india.marketstanding of 5yrs .air content:container should not exceed10ml.external sterility of the blood bags must be assured.the firm must submit published materials in the scientific journals in favours of the quality of blood bags. comply to i.p. must produce qc pass certificate with each lot. 53 double blood bag cpda 350: ce mark, iso 9001 2000, directive 93 / 42 / eec, iso 13485:1996 quality system certification .conformity to iso 3826 international product standard for blood bags.needle should generate less than 17 gm force of resistance thus ensuring virtually painless venepuncture every time, blood bags should be welded with high frequency sealing technology which ensures that bags do not break even when centrifuged at high speeds.markings in the tubing : segment numbering through thermic technology and numbers should be very clear, legible and readable with out any strains to eyes. should have needle injury protector, predonation sampling bag & leur adaptor.must produce qc pass certificate with each lot. 54 double blood bag cpda 450 : ce mark, iso 9001 2000, directive 93 / 42 / eec, iso 13485:1996 quality system certification. conformity to iso 3826 international product standard for blood bags. needle should generate less than 17 gm force of resistance thus ensuring virtually painless venepuncture every time. blood bags should be welded with high frequency sealing technology which ensures that bags do not break even when centrifuged at high speeds. markings in the tubing: segment numbering through thermic technology and numbers should be very clear, legible and readable without any strains to eyes. comply to i.p. must produce qc pass certificate with each lot. should have needle injury protector, predonation sampling bag & leur adaptor. 55 triple blood bag cpd with sagm 450 : ce mark, iso 9001 2000, directive 93 / 42 / eec, iso 13485:1996 quality system certification .conformity to iso 3826 international product standard for blood bags.needle should generate less than 17 gm force of resistance thus ensuring virtually painless venepuncture every time, blood bags should be welded with high frequency sealing technology which ensures that bags do not break even when centrifuged at high speeds.markings in the tubing : segment numbering through thermic technology and numbers should be very clear, legible and readable with out any strains to eyes. comply to i.p. must produce qc pass certificate with each lot. should have needle injury protector, predonation sampling bag & leur adaptor. 56 triple blood bag cpda without sagm 350: ce mark, iso 9001 2000, directive 93 / 42 / eec, iso 13485:1996 quality system certification .conformity to iso 3826 international product standard for blood bags.needle should generate less than 17 gm force of resistance thus ensuring virtually painless venepuncture every time, blood bags should be welded with high frequency sealing technology which ensures that bags do not break even when centrifuged at high speeds.markings in the tubing : segment numbering through thermic technology and numbers should be very clear, legible and readable with out any strains to eyes. should have needle injury protector, predonation sampling bag & leur adaptor.must produce qc pass certificate with each lot. 79 apheresis hydroxy ethyl starch 6% in isotonic sodium chloride intravenous infusion 500 ml 80 apheresis single donor plasma kit ( haemanetics ) mcs+ 81 apheresis therapeutic plasma exchange kit ( haemanetics ) mcs+ 82 biological indicator for autoclave made up of an external plastic tube with a perforated cap which made it available for the gaseous interchange contains inside inoculated spore in a filter paper strip & an ampoule with an adequate culture medium & a ph indicator prepared for the o.e.& steam sterilization process and allows an exactly biological controll with results in a maximum period of 48 hrs 83 blood transfusion set sterilized 84 coombs controll cells a panel of 3% reagent red cells for quality controll of anti human globulin procedure, pack size. should be of 2 ml each, company should provide qc report with each vial supplied, iso 13585 85 gel card matrix abd forward and reverse grouping card with auto controll 24 card 86 gel card matrix abo forward group card 87 gel card matrix abo reserve grouping & card 24 card 88 gel card matrix ahg crossmatch card 24 card 89 gel card matrix diluent 2 ( liss ) 250 mlp 90 gel card matrix grouping & confirmation card 24 card 91 gel card matrix neonete grouping card24 card 92 microcuvette for hemocue donor hb checker system ( model hemocue hb 301 ) 93 platelet agitator graph ( penpol ) 7days 0 / 40 94 platelet agitator graph ( remi ) part no. 4w32 10 95 appropriateely diluted monoclonal anti d igg and red cell preserving solution starter pack for preparation of coombs controll cells in situ, pack size. should be 10 ml, should have long expiry, company should provide qc report with each vial supplied, iso 13585 96 bio tips ( microtips ) , 002 100microliter, neutral color 97 bio tips ( microtips ) , 002 100microliter, yellow color 98 bio tips ( microtips ) , 002 200microliter, neutral color 99 bio tips ( microtips ) , 002 200microliter, yellow color 100 calibrator for 3 part cell counter ( usable for sysmex kx 21 ) 101 glass microscopic slides belgium thickness 1 to 1.3mm x75mm×25mm pkt. of 50 slides / box 102 brush for test tube cleaning ( nylon ) 103 micropipette variable volume, single channel, 000.5 0050microlitre•fully autoclavable•light weight & ergonomics design for user comfort•no sharp edges to tear gloves•soft touch tip ejection•color d volume range for easy identification•automatic locking of set volume•one handed operation for safe handling of potentially infectious materials•super blow out formicroorganisms volume pipetting.•easy in laboratory recalibration & maintenance.•three years of warranty 104 micropipette variable volume, single channel, 0002 0010microlitre•fully autoclavable•light weight & ergonomics design for user comfort•no sharp edges to tear gloves•soft touch tip ejection•color d volume range for easy identification•automatic locking of set volume•one handed operation for safe handling of potentially infectious materials•super blow out formicroorganisms volume pipetting.•easy in laboratory recalibration & maintenance.•three years of warranty 105 micropipette variable volume, single channel, 0002 0020microlitre•fully autoclavable•light weight & ergonomics design for user comfort•no sharp edges to tear gloves•soft touch tip ejection•color d volume range for easy identification•automatic locking of set volume•one handed operation for safe handling of potentially infectious materials•super blow out formicroorganisms volume pipetting.•easy in laboratory recalibration & maintenance.•three years of warranty 117 apheresis acd anticoagulant solution ( 500 ml ) , iso 3826 certified. 118 puncture proof container suitable for disposal of sharp biomedical waste and suitable for safe, contamination free disposal of needle and other sharp objects. container should be autoclavable at 121 degree celcius. capacity : 0.6 liters. 119 puncture proof container suitable for disposal of sharp biomedical waste and suitable for safe, contamination free disposal of needle and other sharp objects. container should be autoclavable at 121 degree celcius. capacity : 1.8 liters. 120 puncture proof container suitable for disposal of sharp biomedical waste and suitable for safe, contamination free disposal of needle and other sharp objects. container should be autoclavable at 121 degree celcius. capacity : 5.0 liters....